The chondroitin 6-sulfate oligosaccharide unit of human thyroglobulin promotes the induction of experimental autoimmune thyroiditis via CD44-mediated co-stimulation of murine Th1/Th17 cell differentiation by Lepore, Alessio
Doctorate Program in Molecular 
Oncology and Endocrinology
Doctorate School in Molecular 
Medicine
XXVI cycle - 2010–2013
Coordinator: Prof. Massimo Santoro
“The chondroitin 6-sulfate oligosaccharide 
unit of human thyroglobulin promotes the 
induction of experimental autoimmune 
thyroiditis via CD44-mediated co-stimulation 
of murine Th1/Th17 cell differentiation”
Alessio Lepore
University of Naples Federico II
Dipartimento di Medicina Molecolare e Biotecnologie Mediche
1
Administrative Location
Dipartimento di Medicina Molecolare e Biotecnologie Mediche
Università degli Studi di Napoli Federico II
Partner Institutions
Italian Institutions
Università degli Studi di Napoli “Federico II”, Naples, Italy
Istituto di Endocrinologia ed Oncologia Sperimentale “G. Salvatore”, CNR, Naples, Italy
Seconda Università di Napoli, Naples, Italy
Università degli Studi di Napoli “Parthenope”, Naples, Italy
Università degli Studi del Sannio, Benevento, Italy
Università degli Studi di Genova, Genova, Italy
Università degli Studi di Padova, Padova, Italy
Università degli Studi “Magna Graecia”, Catanzaro, Italy
Università degli Studi di Udine, Udine, Italy
Foreign Institutions
Université Libre de Bruxelles, Bruxelles, Belgium
Universidade Federal de Sao Paulo, Brazil
University of Turku, Turku, Finland
Université Paris Sud XI, Paris, France
University of Madras, Chennai, India 
University Pavol Jozef Šafàrik, Kosice, Slovakia
Universidad Autonoma de Madrid, Centro de Investigaciones Oncologicas (CNIO), Spain 
Johns Hopkins School of Medicine, Baltimore, MD, USA
Johns Hopkins Krieger School of Arts and Sciences, Baltimore, MD, USA
National Institutes of Health, Bethesda, MD, USA
Ohio State University, Columbus, OH, USA
Albert Einstein College of Medicine of Yeshiwa University, N.Y., USA
Supporting Institutions
Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli 
“Federico II”, Naples, Italy
Istituto di Endocrinologia ed Oncologia Sperimentale “G. Salvatore”, CNR, Naples, Italy
Istituto Superiore di Oncologia, Italy
2
Italian Faculty
Salvatore Maria Aloj
Vittorio Enrico Avvedimento
Francesco Beguinot
Maria Teresa Berlingieri
Roberto Bianco
Bernadette Biondi
Francesca Carlomagno
Maria Domenica Castellone
Gabriella Castoria
Angela Celetti
Annamaria Cirafici 
Annamaria Colao
Gerolama Condorelli
Vittorio De Franciscis
Sabino De Placido
Gabriella De Vita
Monica Fedele 
Pietro Formisano
Alfredo Fusco
Fabrizio Gentile
Domenico Grieco
Michele Grieco
Maddalena Illario
Paolo Laccetti
Antonio Leonardi
Paolo Emidio Macchia
Rosa Marina Melillo
Claudia Miele
Nunzia Montuori
Roberto Pacelli
Giuseppe Palumbo
Maria Giovanna Pierantoni
Rosario Pivonello
Giuseppe Portella
Maria Fiammetta Romano 
Giuliana Salvatore
Massimo Santoro
Donatella Tramontano
Giancarlo Troncone
Giancarlo Vecchio 
Giuseppe Viglietto
Mario Vitale
3
“The chondroitin 6-sulfate 
oligosaccharide unit of human 
thyroglobulin promotes the induction 
of experimental autoimmune 
thyroiditis via CD44-mediated co-
stimulation of murine Th1/Th17 cell 
differentiation”
4
Table of contents
LIST OF PUBLICATIONS.................................................................................7
ABSTRACT........................................................................................................8
1 INTRODUCTION.......................................................................................9
1.1 Experimental autoimmune thyroiditis (EAT).......................................9
1.2 Genetic regulation of susceptibility to EAT ........................................9
1.3 Thyroglobulin ....................................................................................11
1.4 Structure and function of human thyroglobulin (hTg).......................11
1.4  1 The Tg gene: structure and evolution.............................................11
1.4  2 Structure of hTg.............................................................................11
1.4  3 Post-translational modifications of hTg: glycosilation..................12
1.4  4 Chondroitin 6-sulfate oligosaccharide units..................................13
1.5 Effects of chondroitin sulfate proteoglycans......................................14
1.6 Involvement of CS in Experimental Autoimmune Thyroiditis..........15
1.7 CD 44: gene, structure and function .................................................17
1.8 CD44 as co-stimulatory molecule in adaptive and innate immune 
responses .................................................................................................19
1.9 CD44 as mitogenic and antiapoptotic molecule in adaptive immune 
responses .................................................................................................20
2     AIM OF THE STUDY...........................................................................22
3 MATERIALS AND METHODS...............................................................23
3.1 Preparation of hTg and isolation of hTgCS from hTgCS0 ...............23
3.2 Purification, derivatization and p-Azidobenzoyl hydrazid cross 
linking of the hTgCSgp glycopeptide .....................................................23
3.3 Experimental animals.........................................................................24
3.4 EAT induction....................................................................................24
3.5 Evaluation of EAT .............................................................................25
3.6 Assay of T4 and T3 in mice sera........................................................25
3.7 Secondary proliferative and secretory responses of splenocytes in 
vitro..........................................................................................................25
3.8 Serum antibody assays.......................................................................26
3.9 Isolation of murine CD4+ cells..........................................................26
3.10 Secondary proliferative and secretory responses of lymphocytes 
CD4+ in vitro...........................................................................................27
3.11 Cross-linking of hTgCSgp to T cells receptors and Western blot....27
3.12 Confocal microscopy.......................................................................28
3.13 Statistical analysis............................................................................28
4. RESULTS ................................................................................................30
5
4.1. hTgCS is a stronger inducer of EAT compared with hTgCS0 in 
CBA/J(H-2k) mice...................................................................................30
4.2 hTgCS is more effective than hTgCS0 in promoting the primary 
sensitization in vivo of murine splenic lymphocytes to shared epitopes of 
hTgCS0 and hTgCS.................................................................................33
4.3 Enzymatic dechondroitination deprives hTgCS of its enhanced ability 
to sensitize murine lymphocytes to shared hTg epitopes.........................35
4.4 Chondroitinated nonapeptide hTgCSgp isolated from hTgCS displays 
mitogenic activity towards naïve and hTg-sensitized murine splenic 
lymphocytes.............................................................................................36
4.5 The CS unit of hTg, both as a mojety of hTgCS and in the form of 
hTgCSgp glycopeptide, synergizes CD28-mediated costimulation of the 
proliferation of  CD4+ T cells in response to anti-CD3 Abs....................37
4.6 Cytokine secretion patterns in secondary responses of isolated murine 
CD4+ T cells reveal the costimulatory role of the CS unit of hTg and its 
variable impact on the differentiation and phenotypic expression of 
distinct Th cell subsets.............................................................................39
4.7 EAT induction in CBA/J(H-2k) and SJL(H-2s) mice is suppressed by 
PHCCC, a selective inhibitor of Th17 cell differentiation.......................44
4.8 Treatment with PHCCC does not abolish secondary proliferation  of 
CD4+ T cells from SJL mice in vitro in response to hTgCS0 and hTgCS
..................................................................................................................49
4.9 Cytokine secretion patterns in secondary proliferations of splenic 
lymphocytes from mice immunized with hTg with added PHCCC 
treatment reveal a selective impairment of Th17 cell differentiation......50
4.10 CD44 is the receptor of the CS oligosaccharide unit of hTg at the 
surface of murine CD4+ T cells...............................................................52
5 DISCUSSION............................................................................................55
6 ACKNOWLEDGEMENTS.......................................................................61
7 REFERENCES..........................................................................................62
6
LIST OF PUBLICATIONS
1 Zappulla, C., Notartomaso, S., Cetrangolo, G., Fazio, F.,  Busceti,  C., 
Arcaro, A., Galgani, M., Scarselli, P., Lepore, A., Formisano, S., Nicoletti, F., 
Gentile,  F.,  and  Di  Marco,  R.  (2011)  Beneficial  effect  of  mGlu4  receptor 
activation on multiple animal models of autoimmune disease. In: Proceedings 
of  the  7th International  Meeting  on  Metabotropic  Glutamate  Receptors, 
Taormina, October 2-7, 2011, oral presentation.  Current Neuropharmacology 
vol. 9: 68-69, Bentham Science Publishers Ltd. (ISSN: 1570-159X)
2 Pizzimenti, S., Ciamporcero, E., Daga, M., Pettazzoni, P., Arcaro, A., 
Cetrangolo, G., Minelli, R., Dianzani, C., Lepore, A., Gentile, F., and Barrera, 
G.  (2013).  Interaction  of  aldehydes  derived  from  lipid  peroxidation  and 
membrane  proteins.  Frontiers  in  Physiology  vol.  4(242):  1-17. 
doi:10.3389/fphys.2013.00242 (ISSN 1664-042X)
Articles under revision:
1 Arcaro, A., Daga, M., Cetrangolo, G. P., Ciamporcero, E.,  Lepore, A., 
Pizzimenti, S., Petrella, C., Ullio, C., Mamone, G., Ferranti, P., Ames, P. R. J., 
Palumbo, G., Barrera, G., and Gentile, F. Adducts with Heat Shock Protein 60 
and CX49orf are formed in HL-60 human myeloid leukemic cells exposed to 
4-hydroxy-2-nonenal.  A “strange  loop”  of  peroxidative  stress  and  adaptive 
immunity on the way to atherosclerosis?  Mediators of Inflammation,  revision  
pending (manuscript  no.  804531.v1)  (ISSN  0962-9351,  online  ISSN:  1466-
1861)
2 Cetrangolo,  G.  P.,  Arcaro,  A.,  Lepore,  A.,  Graf,  M.,  Mamone,  G., 
Ferranti,  P.,  Palumbo,  G.,  and Gentile,  F.  Hormonogenic  donor Tyr2522 of 
bovine thyroglobulin.  Insight  into  preferential  T3 formation at  the carboxyl 
terminus  of  thyroglobulin  at  low  iodination  level.  FEBS  Letters,  revision  
pending (manuscript no. D-14-00326) (ISSN 0014-5793)
7
ABSTRACT
The  data  presented  in  this  work  document  that  the  presence  of  a 
chondroitin 6-sulphate (CS) oligosaccharide unit linked to Ser2730 of human 
thyroglobulin  (hTg)  was  associated  with  a  marked  increase  of  the 
immunopathogenicity of hTg in a model of murine experimental autoimmune 
thyroiditis (EAT) in CBA/J(H-2k) and SJL(H-2s) mice. When used to immunize 
CBA/J mice, CS-containing hTg (hTgCS) markedly enhanced, in comparison 
with CS-devoid hTgCS0,  the infiltration of murine thyroids by mononuclear 
cells,  the  leak  of  thyroid  hormones  from  thyroid  epithelial  cells  into  the 
bloodstream  and  the  secondary  proliferative  and  secretory  responses  of 
splenocytes  and isolated CD4+ T cells  to both hTgCS and hTgCS0 in vitro. 
These results indicated that the CS oligosaccharide unit of hTg is capable of 
enhancing  markedly the  primary  sensitization  of  murine  T cells  to  peptide 
epitopes shared between hTgCS and hTgCS0 and conserved between human 
and  murine  Tg.  Moreover,  the  cytokine  secretion  patterns  obtained  with 
isolated  murine  CD4+ T cells  indicated  that  the  CS unit,  both  as  a  part  of 
hTgCS and in the form of a purified, CS-containing nonapeptide isolated to 
homogeneity  from  hTgCS  (hTgCSgp),  was  capable  of  enhancing  the 
differentiation of Tg-reactive  TH1 and  TH17  cells. Furthermore, the response 
patterns of murine CD4+ T cells to hTgCS and hTgCSgp, also in relation with 
the responses to anti-CD3 and anti-CD28 antibodies, indicated that the CS unit 
of hTg did not behave as a pathogenic epitope in itself, but rather as an added 
co-stimulus for the differentiation of Tg-specific  TH1 and  TH17 cells, thereby 
promoting strongly thyroid disease. Finally, two-step cross-linking experiments 
and  confocal  microscopy  of  murine  CD4+ T  cells  exposed  to  the  purified 
hTgCS  glycopeptide  indicated  that  the  CS  oligosaccharide  unit  of  hTg 
interacted specifically with CD44 of murine CD4+ T cells.
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1 INTRODUCTION
1.1 Experimental autoimmune thyroiditis (EAT)
Experimental  autoimmune  thyroiditis  (EAT),  a  murine  model  of 
Hashimoto’s thyroiditis, can be induced in mice with   haplotypes H-2s  and H-
2k by immunization with mouse Tg (mTg) or human Tg (hTg) in complete 
Freund’s adjuvant (CFA) or lipopolysaccharide (Rose et al.  , 1971). EAT is 
characterized  by  the  infiltration  of  thyroid  by  mononuclear  cells,  the 
production  of  specific  antibodies  and  in  vitro cell  proliferative  responses 
against Tg. EAT is a T cell-mediated disease, which can be transferred from 
mice immunized with mTg to syngeneic hosts, by injecting mTg-specific T-cell 
clones and cytotoxic T lymphocytes. CD4+ cells play a dominant role in EAT 
(Flynn et al.,  1989). The analysis of the T cell receptor Vβ gene repertoire of 
thyroid-infiltrating T cells, after immunization with Tg or adoptive transfer of 
mTg-primed T cells, showed the clonal expansion of Vβ13+ T cells (Matsuoka 
et al., 1994; Nakashima et al., 1996). Also the characterization of mTg-primed 
T cells, expanded in vitro with staphylococcal enterotoxin A, demonstrated the 
involvement of Vβ13+ and Vβ1+ T cells in subsequent thyroiditis transfer (Wan 
et al., 2001). T helper type-1 responses are crucial for thyroiditis development, 
as underscored by the impaired induction of EAT in interleukin-12-deficient 
C57BL ⁄6 mice (Zaccone et al., 1999) and by the association between the IFN-
γ gene  deletion  and  the  marked  reduction  of  anti-mTg  IgG1  and  IgG2b 
production, and thyroid infiltration with T, B and plasma cells in spontaneous 
autoimmune thyroiditis (SAT)  (Yu et al.,  2002). Anti-Tg antibodies may also 
contribute to the pathogenesis of murine autoimmune thyroiditis.  Moreover, 
some murine mAbs facilitated the internalization of mTg by a murine B-cell 
hybridoma in vitro, and either suppressed or enhanced the presentation of the 
non-dominant pathogenic epitope 2549–2560 (Dai et al., 1999). In NOD-H-2h4 
mice,  the  levels  of  mTg-specific  IgG1 and  IgG2b  autoantibodies  produced 
correlated  closely  with  the  severity  of  SAT  (Braley-Mullen et  al.,  1999). 
Moreover, B cell-deficient NOD-H-2h4 mice developed minimal SAT, and B 
cell function could not be replaced by anti-mTg antibodies (Braley-Mullen et  
al., 2000).
1.2 Genetic regulation of susceptibility to EAT 
The development of  EAT is under the influence of H-2 molecules of 
the murine major hystocompatibility complex (Vladutiu 1989;  Beisel et al.,  
1992).  High  susceptibility  strains  include  C3H(H-2k)  and  SJL(H-2s),  while 
BALB/C(H-2d) and B10(H-2b) are relatively resistant. Non-obese diabetic mice 
(NOD)(H-2g7), a strain susceptible to diabetes, are also prone to develop SAT, 
even though at a very low rate with aging (Damotte et al., 1997). In the context 
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of the “high-responder” haplotype H-2k, the region H-2A of the H-2 complex is 
the major  regulator  of  the susceptibility to  EAT (Beisel et  al.,  1982),  even 
though the regions K and D of the H-2 complex also have influence (Kong et  
al., 1979). The primary response of mouse lymphocytes to epithelial syngeneic 
thyroid cells is under a similar control by the H-2 region, and their proliferation 
seems to be triggered  by the recognition of products  of  the  I-A subregion 
(Salamero and Charreire 1983a and 1983b).  Therefore,  the recognition of a 
limited number of thyroiditogenic epitopes of mTg and hTg by HLA-restricted 
T lymphocytes  seems  pivotal  in  the  development  of  EAT.  Apparently,  H-2 
molecules are able to present T cell thyroiditogenic epitopes shared by mTg 
and hTg. 
By  using  mice  characterized  by  recombination  within  the  H-2 region, 
differences in the genetic influence on the induction of EAT by thyroiditogenic 
peptides  of  Tg  have  been  observed,  in  comparison  with  EAT induction  by 
whole  Tg,  which  is  under  strong influence  by H-2Ak products.  The rat  Tg 
peptide TgP1 causes EAT with a  similar genetic pattern as entire Tg: B10.BR 
and C3H(H-2k) and SJL(H-2s) mice are susceptible, while BALB/C(H-2d) are 
partially resistant and B10(H-2b) are resistant. At variance from EAT induction 
by  intact  Tg,  EAT induction  by  TgP1  (2495-2511),  within  the  susceptible 
haplotype  H-2k,  requires  the  expression  of  H-2E  products,  while  the  H-2D 
region does  not  seem to  have  influence.  Such divergences  probably reflect 
differences in antigen processing and presentation between Tg and its peptides. 
The role of H-2E molecules in the presentation of peptides such as TgP1 could 
be  masked,  if  most  thyroiditogenic  Tg  epitopes  were  H-2Ak-restricted. 
Moreover, the non-immunodominant peptide TgP1 could be displaced by other 
peptides of Tg in the interaction with H2-E molecules, or, alternatively, it may 
not  be  generated  by  antigen  presenting  cells  (APC),  in  the  course  of  Tg 
proteolysis, whereas it may be generated and presented by intrathyroidal MHC 
class I- or class II-positive cells (Chronopoulou et al.,  1993). Subsequently, it 
has been demonstrated that  the 2496-2504 nonamer was the minimal  T-cell 
epitope in TgP1 and could be presented within the context of the non-isotypic 
H-2Ek molecules of C3H(H-2k) mice and H-2As molecules of SJL(H-2s) mice 
(Rao et al.,1994). On the other hand, the genetic pattern of mouse susceptibility 
can vary, depending on the pathogenic epitope: rTg peptide 2696-2713 (TgP2) 
caused EAT in SJL(H-2s) mice, but not in C3H or B10.BR(H-2k), BALB/c(H-
2d), and B10(H-2b) mice (Carayanniotis et al., 1994).
Last, the role of polymorphic genes  HLA-BR1 (DR3) in the development of 
EAT following Tg immunization has been addressed using HLA-DR and HLA-
DQ transgenic mice: immunization of  HLA-BR1*0301(DR3) transgenic mice 
with  mTg  or  hTg  resulted  in  severe  thyroiditis,  while  transgenic  mice 
expressing  HLA-BR1*1502(DR2) gene  were  resistant  to  EAT  (Kong et al.,  
1996). The introduction of the H-2Eak transgene into B10(H2b) or MHC class 
II-negative Ab0 mice, both resistant to EAT, conferred upon them susceptibility 
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to EAT induced by bovine, porcine or human Tg, but not murine Tg (Wan et  
al., 1999).
1.3 Thyroglobulin 
Thyroglobulin  is  a  large  homodimeric  glycoprotein,  with  a  Mr  of 
660,000. After being synthesized and assembled into dimers in the endoplasmic 
reticulum and glycosylated in the Golgi apparatus, it is condensed in secretory 
granules in the apical cytoplasm of thyroid follicular cells and secreted in a 
regulated way in the lumen of tyroid follicles. Thyroglobulin is the molecular 
site of biosynthesis of thyroid hormones, which are synthesized through the 
iodination and coupling of a small number of specific tyrosyl residues within 
the context of the polypeptide chains of thyroglobulin. Thyroglobulin is also a 
major  autoantigen,  involved  in  the  pathogenesis  of  thyroid  autoimmunity 
(Gentile et al., 2004).
1.4 Structure and function of human thyroglobulin (hTg)
1.4  1 The Tg gene: structure and evolution
The hTg gene is located on chromosome 8 and it is one of the gratest 
genes known,  encompassing  42 exons and spanning more than  300,000 base 
pairs  (Baas  et al.,  1986). About two-thirds of Tg at  its  amino-terminal side 
consist of tandemly repeated cysteine-rich motifs of various kinds. This portion 
of the hTg gene probably derives from duplication of an ancestral unit made of 
four  exons.  The  carboxy-terminal  third  of  Tg  is  homologous  with 
acetylcholinesterase and appears to have been originated from the duplication 
of an ancestral gene, in common with a superfamily of esterases (Takagi et al.,  
1991; Krejci et al.,  1991). Thus, Tg appears to be made of two mojeties, an 
amino-terminal  one and a  carboxy-terminal  one,  with different  evolutionary 
histories, both being able to support the biosynthesis of thyroid hormones.     
1.4  2 Structure of hTg
The full-length sequence of the hTg mRNA has been determined from 
overlapping cDNA clones (Malthiéry and Lissitzky 1987). It consists of 8448 
nucleotides, including an untranslated 5′-end, an open reading frame, and an 
untranslated 3′-end, and encodes a polypeptide of 2767 amino acids. The first 
19 residues probably represent a  hydrophobic signal sequence and are absent 
from the  mature  protein,  which  is  composed  of  2749  residues  and  has  an 
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expected Mr of 302,773. Two-thirds of the Tg sequence at its amino-terminal 
side consist  of tandemly repeated motifs. The type-1 motif  is 60-70-residue 
long, contains 6 cysteinyl residues, and is repeated 10 times. The type-2 motif 
consists of 14 to 17 amino acids, 2 of which are cysteines, and is repeated 3 
times at the center of Tg. Five type-3 repeats, subdivided into three subtype-3a 
repeats, with 8 cysteines each, and 2 subtype-3b repeats, with 6 cysteines each, 
follow in alternating order. The type-1 motif is homologous with a cystein-rich 
Fig 1. Polipeptide chain of hTg with the localization of the B and T cells epitopes.  
motif  of  the  invariant  chain  associated  with  the  class  II  major 
histocompatibility antigen (McKnight et al., 1989). The sequence of 570 amino 
acids at the COOH-terminus of Tg shows a high degree of similarity (up to 
60% in some regions) with those of the members of a superfamily of lipases 
and esterases, including the acetylcholinesterase of Torpedo californica, human 
serum cholinesterase,  and others  (Takagi  et  al.,  1991;  Krejci et  al.,  1991). 
Mature  hTg  is  a mixture  of  both  non-covalent  and  covalent  homodimers, 
having a molecular mass of 330,000.
1.4  3 Post-translational modifications of hTg: glycosilation
Carbohydrates contribute about 10 per cent of the Tg mass. Two kinds 
of oligosaccharide units (A and B) are attached by glycosylamine linkages to 
asparagine residues of Tg. High-mannose A units contain a variable number (7-
9) of mannose residues and 2 N-acetylglucosamine residues. Complex B units 
contain 3 mannose residues and a variable number of  N- acetylglucosamine, 
galactose, fucose, and sialic acid residues (Arima et al., 1972). Human Tg also 
contains  C  and  D  oligosaccharide  units.  C  units  are  linked  to  serine  and 
threonine  by  O-glycosidic  bonds  and  contain  galactosamine;  D  units  are 
chondroitin-6-sulfate-like  oligosaccharides  linked  to  serine  and  contain  a 
repeating unit  of glucuronic acid and galactosamine,  plus xylose,  galactose, 
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and sulfate (Spiro et al., 1977). 90 per cent of the [35S]-sulfate incorporated into 
human  Tg  is  equally  distirbuted  in:  a)  biantennary  B  units,  containing 
galactose-3-sulfate, and tri- and tetra-antennary B units containing galactose-3-
sulfate  and  N-acetylglucosamine-6-sulfate;  b)  chondroitin-6-sulfate-like  D 
units (Spiro and Bhoyroo 1988; Schneider et al., 1988).
1.4  4 Chondroitin 6-sulfate oligosaccharide units
In a previous study (Conte et al., 2006), we characterized in detail the 
O-linked, type D chondroitin 6-sulfate (CS) oligosaccharide unit of hTg. We 
developed an ion-exchange chromatography (IEC) method, which permitted us 
to separate chondroitin 6-sulfate-containing hTg molecules (hTgCS) from the 
residual hTg molecules (hTgCS0). By exploiting the changes of electrophoretic 
mobility  and  staining properties  conferred  upon  the  products  of  limited 
proteolysis of  hTg  by  chondroitin  6-sulfate  units,  we  first  restricted  the 
chondroitin 6-sulfate-containing regions of hTg to a carboxyl-terminal peptide, 
starting  at  Thr2514.  The  subsequent  purification  of a  homogeneous,  D-
glucuronic  acid-containing  nonapeptide  (hTgCSgp), corresponding  to  hTg 
residues  2726-2734,  permitted  us  to  establish Ser2730  as  the  sole  site  of 
chondroitin 6-sulfate addition in hTg. 
In an ample number of hTg preparations, the fraction of hTgCS in total hTg 
ranged from 32.0 to 71.6%. The CS unit was composed of a broadly varying 
number of  D-glucuronic acid-N-acetyl-D-galactosamine disaccharide units.  In 
some goiter hTg preparations with high contents of CS, hTgCS heterodimers,
 
Fig 2 . Structure and localization of chondroitin-6 sulfate oligosacarride unit of hTg: The 
figure show carbossi-terminal segment (2710-2749) of hTg linked by CS. CS is composed by 
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xilose, galattose and N-acetilglucosammine disaccharide glucuronic acid sulfate repeated from 
7 to 11 times (Spiro, 1977).
in which only one hTg subunit contained a CS chain, coexisted with hTgCS 
homodimers.  In  the  monomers  deriving  from the  dissociation  of  hTgCS in 
urea, the net number of disaccharide units per chondroitin 6-sulfate chain did 
not exceed 14. We also showed that hTgCS has a higher efficiency of hormone 
formation than hTgCS0, and that the whole unfractionated hTg benefits from 
this  property.  Thus,  chondroitin  6-sulfate  addition represents  an  ergonomic 
mechanism,  by  which  the  post-translational modification  of  a  fraction  of 
molecules influences the overall function of hTg. 
Furthermore, we identified two sites, one between Lys2714 and  Gly2715 and 
the other between Lys2745 and Thr2746, near the site of chondroitin 6-sulfate 
addition, which were susceptible to limited proteolysis with trypsin. Our data 
show that the former was protected from proteolysis in hTgCS but not in hTg-
CS0.  We reasoned that  the addition of  the  C6S chain may exert  modifying 
effects in the processing of hTg by antigen-presenting cells and in the ability of 
hTg  to  function  as  an  autoantigen.  These  may  go  beyond  the  possible 
influences on the proteolytic accessibility and/or the recognition of specific T- 
and B-cell epitopes located in the vicinity of the chondroitin 6-sulfate addition 
site.
1.5 Effects of chondroitin sulfate proteoglycans
Chondroitin sulfate proteoglycans play important roles in cell adhesion, 
migration, differentiation and proliferation. Several reports indicate that some 
chondroitin sulfate proteoglycans affect the proliferation of a number of cell 
types. Versican 1 and 2 have opposite actions on the proliferation of NIH-3T3 
cells:  versican  1  induces  cell  proliferation  and  inhibits  apoptosis,  while 
versican 2 inhibits cell proliferation and does not affect apoptosis (Sheng et al.,  
2005). TENB2, a chondroitin sulfate proteoglycan identified in prostate cancer, 
is involved in disease progression and in prostatic cell growth control (Glynne-
Jones  et  al.,2001).  The  degradation  of  chondroitin  sulfates  A,  B  and  C 
chondroitinase reduces  the proliferation and invasion capacity of  melanoma 
cells,  while  inducing  caspase-3  activity  and  thus  stimulating  apoptosis 
(Denholm et  al.,  2001).  Endothelial  cells,  treated  with  the  same  enzymes, 
behave similarly. Some Authors (Yang et al.,2004), by studying the chondroitin 
sulfate  proteoglycan  of  melanoma  cells  (MCSP),  demonstrated  that  it 
stimulates proliferation, migration and invasion by tumor cells, by enhancing 
FAK  and  ERK  activation.  By  studying  globular  domains  of  proteoglycan 
molecules,  specific  regions  were  identified,  modulating  cellular  responses, 
such as apoptosis or cell proliferation (Cattaruzza et al., 2004). 
The action of chondroitin sulfate proteoglycans is often mediated by CD44, the 
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most  important  chondroitin  sulfate  proteoglycan  exposed  on  the  leukocyte 
surface (Taylor and Gallo 2006). 
Generally, high levels of proteoglycan chondroitin sulfates are predictive of a 
poor prognosis and malignant progression of the disease. It is conceivable that 
the  hTgCSgp  glycopeptide  may  be  involved  in  the  progression  of  thyroid 
tumours and may induce cellular proliferation and inhibition of apoptosis. 
1.6 Involvement of CS in Experimental Autoimmune Thyroiditis
CS  unit  might  influence  the  ability  of  hTg  to  induce  experimental 
autoimmune thyroiditis (EAT) in genetically susceptible mice in several ways:
1.  The  influence  of  the  CS  oligosaccharide  chain  on  the  proteolytic 
susceptibility of the extreme carboxy-terminal region of hTg could modify the 
processing  and  presentation  of  hTg  by  antigen-presenting  cells  (APCs), 
particularly  because  the  site  of  CS  addition  to  hTg  is  localized  within  an 
epitope-rich  region,  harboring  several  T  cell-  and  B  cell-related  epitopes 
(Gentile et al.,  2004).  O-linked mono- and disaccharides in tumor-associated 
glycoprotein  MUC1  restricted  the  repertory  of  epitopes  produced  and/or 
presented  in  a  site-specific  manner,  either  by  limiting  the  accessibility  of 
specific cleavage sites to cathepsin L (Hanisch et al.,  2003), or by preventing 
epitope  recognition  by  a  peptide-specific  T  cell  hybridoma.  N-linked 
oligosaccharide  chains  also  inhibited  the  generation  of  a  self  epitope  from 
glutamate  receptor  subunit  3  (Gahring et  al.,2001),  and  of  cytotoxic 
lymphocyte (CTL)-specific epitopes from influenza A nucleoprotein (Wood et  
al.,1998). Conceivably, the CS oligosaccharide unit in hTgCS may hamper the 
processing  by APCs  of  the  surrounding  hTg  region,  within  a  range  which 
includes  the  Lys2714-Gly2715  bond,  at  the  amino  side,  and  the  Lys2745-
Thr2746 bond, at the carboxy side.
2.  Direct  effects  of  chondroitin  sulfate  oligosaccharide  units  on  cellular 
immune responses have been documented:
• Ii  (invariant  chain,  CD74)  is  a  non-polymorphic  glycoprotein  that 
participates in a number of immunological functions. The major functions 
of  Ii  are  mediated  through  its  association  with  MHC-II  heterodimers 
(Hiltbolt et al. ,2002). In the ER, newly synthesized Ii self assembles into 
trimers. Three class II heterodimers are sequentially added to one Ii trimer 
to form a nine-chain complex. In the ER, Ii facilitates MHC-II heterodimer 
assembly and folding and occupies the MHC-II-binding groove, preventing 
premature  binding  of  either  peptides  or  unfolded  polypeptides.  The 
nonameric complex transits through the Golgi and is transported to late 
endosomes/lysosomes, where Ii is degraded, allowing MHC-II to be loaded 
with peptide. However, it has been shown that a small percentage (2-5%) 
of Ii molecules associated with class II MHC molecules are modified with 
the addition of a single chondroitin sulfate chain at Ser 291. Chondroitin 
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sulfate-containing invariant chain complexes (Ii-Cs) are transported rapidly 
from the trans-Golgi network to the cell surface, in spite of the presence of 
an  intact  endosomal  localization  signal.  In  this  form,  they  remain 
associated with class II molecules at the surface of APCs (Sant et al.,1985;) 
(Miller et  al.,  1988), where  they act  as  accessory molecules  in  antigen 
presentation,  through  interaction  with  CD44 (Naujokas  et  al.  ,2003). 
Recently,  it  has  been  demonstrated  that  the  presence  of  at  least  one 
chondroitin  sulfate-containing  subunit  within  the  context  of  Ii/MHC-II 
nonamers is  able to direct  Ii  to the cell  surface (Arneson  et  al.,  2007). 
Enhancing effects of Ii (CD74) on T cell mitogenic and allogenic responses 
occur through the interaction of Ii-CS (CD74) with CD44 on responding T 
cells,  as  they can be inhibited  both  by anti-CD44 antibodies,  and by a 
soluble  form of  CD44  (CD44Rg)  (Naujokas et  al.,  1993). Monoclonal 
antibodies against CD44 were able to trigger the cytotoxic activity of CTL 
in  a  TCR-independent  manner  (Seth et  al.,  1991). Serglycins,  small 
proteoglycans in secretory granules of hematopoietic cells, activated the 
CD3-dependent  release  of  cytokines  and  proteases  from CD44-positive 
CTL clones (Toyama-Sorimachi et  al., 1995), by interacting with CD44 
through  their  chondroitin  4-sulfate  and  6-sulfate  side  chains  (Toyama-
Sorimachi et  al., 1997). Moreover,  the  binding  of  aggrecan  to  CD44, 
through its chondroitin 4- and 6-sulfate side chains, was able to trigger the 
oligomerization  of  CD44  molecules  and  the  intracellular  signaling 
(Fujimoto et al.,  2001). Both CD44v6 and CD44v7 were transiently up-
regulated during lymphocyte activation. Antibodies to CD44s and CD44v7 
inhibited antigenic and mitogenic T and B cell responses, while antibodies 
to CD44v6 selectively inhibited T cell responses (Seiter et al., 2000).  
• More  recently,  Ii-CS  (called  CD74)  has  been  identified  as  the  cell-
surface receptor for Macrophage migration inhibitory factor (MIF) (Leng, 
2003). MIF  promotes  pro-inflammatory  cytokine  production  by 
macrophages, triggers proliferation of T cells, and induces the release of 
nitric oxide, matrix metalloproteases, COX-2, and prostaglandin E2. MIF 
binds  to  Ii  by  a  high-affinity  interaction  and  induces  the  serine 
phosphorylation  of  the  CD74  intracytoplasmic  domain  in  a  CD44-
dependent manner. CD44 might be necessary for many, if not all, of MIF’s 
signal  transduction  properties.  By  using  COS-7/M6  (deficient  in  both 
CD74 and CD44) cell lines engineered to stably express combinations of 
CD74,  CD44,  and  CD44D67,  some  Authors  found  that  CD74  alone 
imparts MIF binding to cells and that the presence of CD44 did not confer 
additional  binding  activity  over  that  of  CD74  alone.  There  are  not 
evidences  for  a  specific  interaction  between  MIF  and  CD44;  however, 
MIF-mediated ERK1 and ERK2 activation required the expression of a full 
length  CD44.  MIF stimulation  was  associated  with  the  PKA-dependent 
serine phosphorylation of CD74 and CD44. Investigations with siRNA and 
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the  kinase  inhibitor  PP2  indicate  that  MIF-induced  ERK  activation 
proceeded  via  the  Src  tyrosine  kinase,  which  was  previously shown to 
associate physically with the CD44 intracytoplasmic domain (Taher et al.,  
1996). 
• Finally, it has been demostrated that  p41 fragment of  invariant chain 
(containing an additional 64-amino acid sequence in the lumenal domain) 
is  a  potent  inhibitor  of  cathepsin  L.  The  additional  segment  (AS)  is 
cysteine rich, and shares significant homology with the type-1 repetitive 
sequence of thyroglobulin (Bevec et al. ,1996). These data suggest that p41 
may enhance Ag presentation, by reducing the proteolytic activity of the 
Ag-processing compartment, thus protecting a subset of antigenic epitopes 
from excessive degradation (Fineschi et al. ,1996).
1.7 CD 44: gene, structure and function 
CD 44 is a monomeric ubiquitous transmembrane type 1 protein that is 
the most important receptor of hyaluronic acid (HA) and other extracellular 
matrix glycoproteins.
CD44 gene is located at the short arm of 11 choromosome, containing 20 exons 
spanning some 50 kilobases of DNA. Exons 1÷16 encode extracellular domain, 
exon  17  encode  trasmembrane  domain  and  exons  18,  19  encode  for 
cytoplasmatic domain.   Exons 6÷15 are subjected to alternative splicing with 
the formation of ten alternative splicing forms of the CD44 protein named V1 ÷ 
V10 that have different and specifics functions (Ponta et al., 2003).
CD44 structure consist of:
1-Extracellular ammino-terminal domain that contains globular acid hyaluronic 
binding domain (HBD). This domain has motifs that function as docking sites 
for several components of ECM. In the ammino-terminal globular region of 
CD44,  a  stretch  of  90  amino  acid  (residues  32-123)  shows  considerable 
homology with both the cartilage link protein and with the proteoglycan core 
protein. This domain is known as the “link” domain, that enable CD44 to bind 
to hyaluronan. HBD of CD44 smallest isoform (CD44s) is separated from the 
plasma  membrane  by  a  short  stem  structure  (46  amino  acid).  This  stem 
contains putative proteolytic cleavage sites. The stem structure is enlarged by 
sequences that are encoded by the alternatively spliced exons of CD44 (Ponta 
et al. ,2003);
2- Transmembrane domain composed of 21 hydrophobic amino acids and a 
cysteine  residue  which  seem  to  partecipate  in  the  formation  of  CD44 
oligomers. The transmembrane domain might be responsible for the association 
of CD44 proteins with LIPID RAFTS (Ponta et al. ,2003); 
3-Cytoplasmatic domain composed of 72 amino acids, that is the target of PKC 
phosphorylation in serine residue. Members of 4.1 superfamily, in particular 
the so-colled ERM (ezrin, radixin, moesin) proteins and ankyrin, a protein that 
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mediates contact with the cytoskeletal component spectrin, interact with a basic 
amino acids motifs of cytoplasmatic domain (Ponta et al. ,2003).  
Structural and functional diversity of CD44 is generated by alternative splicing 
and  post-trascritional  glycosilation.  HBD  domain  is  highly  glycosilated  in 
serine, proline and treonine residues. In this region there are five conserved 
residues for N-linked glycosilation and four serine-glycine (SG) peptides that 
are  linked  to  glycosaminoglycans.  All  CD44  isoforms  are  modified  with 
chondroitin sulfate (CS). The chondroitin sulfate is added to a serine-glycine 
(SG) site in exon 5, while heparan sulfate and chondroitin sulfate are added to 
the SGSG site in exon V3, (Wolff et al. , 1999). CD44 is involved in leukocyte 
adhesion, rolling and migration. The binding of CD44 to hyaluronan is induced 
on  T  lymphocytes  after  activation  by  antigen  and  on  monocytes  after 
stimulation by inflammatory agents. Under inflammatory conditions, CD44 on 
endothelial cells presents hyaluronan to CD44 on activated T lymphocytes and 
mediates a rolling interaction under flow conditions. This rolling interaction, 
together  with  chemokine  signaling  upregulates  integrin  mediated  adhesion, 
induces cell arrest and leads to subsequent migration to the inflammatory site. 
Studies with monoclonal antibodies against CD44 in mouse models of chronic 
inflammatory disease showed reduced disease severity attributed to reduced 
Fig 3. CD44 transcripts and proteins: a  CD44 pre-mRNA is encoded by 20 exons, 10 of 
which  can  be  regulated  by  alternative  splicing  (variant  or  'v'  exons).  The  smallest  CD44 
isoform, which is known as CD44 standard (CD44s), is ubiquitously expressed in vertebrates 
in developing and adult organisms whereas the larger variant isoforms are expressed in only a  
few epithelial  tissues,  mainly in  proliferating  cells,  and  in  several  cancers.  b The  protein 
structure of CD44s is compared with that of the largest variant isoform CD44v1–10, which 
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shows that the sequences encoded by the variant exons are in the stem region. c The amino-
terminal domain of CD44 proteins contains the hyaluronan-binding motifs, which are in the 
'link domain' (amino acids 32–123), and a basic motif that is outside the link domain (amino 
acids  150–158).  Of  key  importance  for  the  stability  of  the  link  module  are  four  highly 
conserved cysteine residues that form interchain disulphide links (Ponta, 2003).   
leukocyte recruitment (Johnson et al.  ,2008). Sulfation is required for selectin 
mediated leukocyte-endothelial cell interactions and inducible sulfation, also, 
was shown to regulate  CD44 mediated  leukocyte  adhesion  at  inflammatory 
sites (Johnson et al. ,2000). Moreover, CD44 mediates the binding of lymphoid 
cells  to CS under static condition,  and this  interaction is sufficient to resist 
hemodynamic shear forces and support the rolling of the cells on CS under 
physiological flow conditions (Murai et al. , 2004). Recent studies have shown 
other important implications of CD44 in different biological processes such as 
the co-stimulatory activity in adaptive and innate immune responses and the 
mitogenetics antiapoptotic responses too.
1.8 CD44 as co-stimulatory molecule in adaptive and innate immune 
responses 
T cell activation requires two signals: a signal from the TCR and a co-
stimulatory signal provided by antigen-presenting cells (APC). CD28 has been 
recognized as  the  principal  co-stimulatory receptor  for  T cell  activation.  In 
addition to CD28, multiple molecules on the T cell  have been described to 
deliver  co-stimulatory  signals.  CD44  is  a  good  co-stimulatory  molecule 
candidate, that provide T cells activation in a CD28 independent manner co-
stimulation.  There  are  many  evidence  of  this.  For  example  the  interaction 
between CD40 ligand and CD40 is critical for activation of T and B cells  in  
vivo. This interaction rapidly induces a novel co-stimulatory activity CD44H 
mediated, distinct from B7 and independent of CD28. Thus, CD44H, rapidly 
induced by CD40L, co-stimulates T cell proliferation by a CD28-independent 
mechanism (Guo et al. ,1996). Interaction between HA and CD44 can regulate 
murine B-cell effector functions and this interactions may play a critical role 
during normal or autoimmune responsiveness of B cells (Rafi  et al.  ,1997). 
When CD4 and CD8 T cells were divided based on expression levels of CD44, 
which  distinguishes  naıve  cells  (CD44  low)  versus those  that  are  antigen-
experienced  (CD44  hight),  IL2  production  by  and  proliferation  of  CD4 
CD44low naıve cells and both sub-populations of CD8 T cells were clearly 
Bcl10-dependent, whereas these same functional properties of CD4 CD44hight 
T cells occurred largely independent of Bcl10. CD4 CD44hight T cells did not 
activate the NF-B pathway in the absence of Bcl10; These CD4CD44 hight 
antigen-experienced  T  cells  efficiently  secreted  IL2  after  T  cell  receptor 
stimulation in NF-kB-independen manner (Zeng et al.  ,2008). Stimulation of 
CD44 through Ab cross-linking or binding to its natural ligands hyaluronan and 
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osteopontin  induced  NKT cells  to  secrete  cytokines,  up-regulate  activation 
markers,  undergo  morphological  changes,  and  resist  activation-induced  cell 
death, whereas conventional T cells only exhibited changes in morphology and 
protection from activation-induced cell death. This CD44-specific stimulation 
of  NKT  cells  correlated  with  their  ability  to  bind  hyaluronan.  Thus, 
fundamental differences in CD44 function between these lymphocyte subsets 
suggest a biological role for CD44 in the innate immune response (Larkin et al.  
,2006). CD44 co-stimulation promotes FoxP3 regulatory T cell persistence and 
function via production of IL-2, IL-10, and TGF-1 (Bollyky et al. ,2009). In the 
end,  artificial  proteoglycans  containing  the  extracellular  domain  of  the  cell 
adhesion  protein  lymphocyte  function-associated  antigen-3  (LFA-3)  (CD58) 
and CD44 motifs modified with CS or a combination of CS and HS showed 
that it retains the ability to engage and trigger the function of its natural ligand 
CD2,  resulting  in  T  cell  activation.  In  addition,  the  glycosaminoglycan-
modified artificial proteoglycan is capable of binding the chemokine RANTES 
(regulated  upon  activation,  normally  T  cell  expressed  and  secreted)  and 
delivering it to human T cells, resulting in enhanced T cell activation (Wolff et  
al. ,1999).
1.9 CD44 as mitogenic and antiapoptotic molecule in adaptive immune 
responses 
Regulation of adaptive immune responses is obtained by a good balance 
of mitogenic and pro-apoptotic factors, CD44 is implicated in the regulation of 
this homeostasis  in  different  ways.  In  fact  CD44  engagement,  either  by 
hyaluronic acid (HA) or anti-CD44 MoAbs, inhibits DNA fragmentation and 
apoptosis induced by DEX and anti-CD3 MoAbsi n  lymphoid cells (Ayroldi et  
al. ,1995). Optimal immunity to micro-organisms depends upon the regulated 
death of clonally expanded effector cells and the survival of a cohort of cells 
that  become  memory  cells.  After  activation  of  naive  T  cells,  CD44,  is 
upregulated. High expression of CD44 remains on memory cells and despite its 
wide usage as a ‘‘memory marker,’’.  Moreover,  CD44 was essential  for the 
generation  of  memory  T  helper  1  (Th1)  cells  by  promoting  effector  cell 
survival.  This  dependency  was  not  found  in  Th2,  Th17,  or  CD8+  T cells 
despite similar expression of CD44 and the absence of splice variants in all 
subsets. CD44 limited Fas-mediated death in Th1 cells and its ligation engaged 
the phosphoinositide 3-kinase-Akt kinase signaling pathway that regulates cell 
survival (Baaten et al.  ,2009). Hyaluronan, exists in a high molecular weight 
(native)  form  and  lower  molecular  weight  form  (HMW-  and  LMW-HA, 
respectively).  These  different  forms  of  hyaluronan  bind to  CD44 but  elicit 
distinct effects on cellular function. The binding of HMW-HA to CD44 inhibits 
cell cycle progression, whereas the binding of LMW-HA to CD44 stimulates 
cell cycle progression of vascular smooth muscle cells. HMW-HA binding to 
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CD44 selectively inhibits the GTP loading of Rac and Rac-dependent signaling 
to  the  cyclin  D1  gene,  whereas  LMW-HA  binding  to  CD44  selectively 
stimulates  ERK  activation  and  ERK-dependent  cyclin  D1  gene  expression 
(Kotapalli  et  al.  ,2008).  CD44v6  is  transiently  expressed  during  T  cell 
activation. CD44 standard form (CD44s)  cross-linking induced ERK1/2, JNK, 
c-jun, and IkBα phosphorylation only in the context of TCR engagement on the 
contrary CD44 variant 6 (CD44v6) cross-linking induced ERK1/2, JNK, c-jun, 
and IkBα phosphorylation in a TCR indipendent manner. This event promotes 
T cell proliferation and protects them from apoptosis.  Furthermore, a CD44-
associated  85-kDa  protein  became  hypophosphorylated  only  after  CD44v6 
cross-linking. Threonine hypophosphorylation of this  protein coincided with 
the  activation  of  MAP and  SAP kinases  (Marhaba et  al.  ,2004).  Finally, 
CD44v6  and  CD44v9  isoforms  exhibit  an  antiapoptotic  effect  because  can 
block Fas-mediated apoptosis, indeed,  colocalize and interact with Fas and an 
anti-CD44v6 antibody can abolish his antiapoptotic effect (Mielgo et al.,2006).
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2     AIM OF THE STUDY
 The regional location of the chondroitin 6-sulfate oligosaccharide unit 
of hTg coincides with a cluster containing some of the best characterized T 
cell-dependent epitopes in murine models of autoimmune thyroid disease. It's 
known that chondroitin sulfate-containing molecules, exert effects on immune 
cell  responses,  so  chondroitin  6-sulfate  oligosacchride  unit  of  hTg  may 
determining and controlling the development of immune responses to hTg.  
The aim of this study was to determine whether and by which mechanisms the 
chondroitin  6-sulfate  oligosaccharide  unit  of  human  thyroglobulin  may 
modulate the immunopathogenicity of hTg  in a murine model of experimental 
autoimmune thyroiditis (EAT).
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3 MATERIALS AND METHODS
3.1 Preparation of hTg and isolation of hTgCS from hTgCS0 
hTg  was  prepared  as  described  (Gentile  and  Salvatore,  1993) from 
informed euthyroid patients,  hemilaryngectomized for  non-thyroidal disease, 
and patients undergoing thyroidectomy for non-familial, simple or multinodular 
goiter. Protein concentration was assayed by measuring the optical absorbance 
at 280 nm. Iodine content was assayed as described, using L-thyroxine as the 
standard (Palumbo et al.,1982). HTg molecules containing type-D (chondroitin 
6-sulfate)  oligosaccharide  units  (hTgCS)  were  separated  from residual  hTg 
molecules, devoid of type-D units (hTgCS0), by ion-exchange chromatography 
on trimethylamino-substituted Q-Sepharose (Q-IEC), using 5-mL HiTrap™ Q-
Sepharose HP columns,  equilibrated in 0.025 M Tris/HCl, pH 7.4 (buffer A). 
Up to 20 mg of hTg in buffer A, plus 0.05 M NaCl, were applied to a column. 
After washing with buffer A, a linear gradient from 0 to 100% of buffer B (1.2 
M NaCl in buffer A) was developed in 24 min, at the flow rate of 2.5 mL/min. 
One-mL fractions were analyzed, or stored at -80 °C until use. All the solutions 
for preparation of hTg and isolation of hTgCS from hTgCS0  were filtered by 
using steritopTM  filter Merk Millipore. The concentration of bacterial endotoxin 
in  hTg,  hTgCS  and  hTgCS0 preparations  to  be  used  both  for  mice 
immunization and secondary splenocyte proliferation assays was measured by 
the Limulus amebocyte lysate test. Sample purity threshold for use with cell 
cultures was set at < 0.01 Endotoxin Units (EU)/mL.
3.2 Purification, derivatization and p-Azidobenzoyl hydrazid cross 
linking of the hTgCSgp glycopeptide 
The chondroitin  6-sulfate-containing glycopeptide of hTg (hTgCSgp) 
was purified as previously described (Conte et al.,  2006). A 40-mg aliquot of 
hTgCS was denatured and reduced, in 15 mL of 0.3 M Tris/HCl, pH 8.0, 6.0 M 
guanidine/HCl, 1 x 10-3 M EDTA, 0.01 M dithiothreitol, at 37 °C for 2 h. The 
reduced  protein  was  carboxymethylated  with  a  5-fold  molar  excess  of 
iodoacetamide, with respect to total –SH groups, at room temperature for 30 
min in the dark. Alkylation was stopped with excess dithiothreitol. The sample 
was  dialyzed  against  0.05  M  Na  phosphate,  pH  7.8,  and  digested  with 
endoproteinase  Glu-C  (protease  V8)  from  Staphylococcus  aureus,  at  the 
enzyme:substrate weight ratio of 1:100, at 37 °C for 18 h. The sample was 
adjusted with concentrated solutions to 0.025 M TrisHCl, 0.1 M NaCl, 2.0 M 
urea, pH 7.4 (buffer C), and loaded onto a 5-mL HiTrap™ Q-Sepharose HP 
column,  equilibrated  in  the  same  buffer.  After  washing  with  buffer  C,  a 
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gradient was started, from 0 to 100% of buffer D (1.2 M NaCl in buffer C) in  
55 min, followed by 100% buffer D for 10 min, at the flow rate of 1 mL/min. 
One-mL fractions were monitored for the optical absorbance at 280 nm and D-
glucuronic  acid  content.  A  single  D-glucuronic  acid-containing  peak  was 
subjected  to  size  exclusion  chromatography on a  1.5-by-100-cm column of 
Bio-Gel P-2, in 0.01 M NH4HCO3. A D-glucuronic acid-containing peak, eluted 
in  the  void  volume,  was  lyophilized  and  further  purified  by  gel 
chromatography on a 0.5-by-40-cm column of Sephadex G-50 fine, in 0.01 M 
NH4HCO3.  One-mL  fractions  were  monitored  for  peptide  content,  by 
measuring the optical absorbance at 220 nm, and  D-glucuronic acid content, 
and a single peptide- and  D-glucuronic acid-containing peak was lyophilized. 
Aliquots of 150 nmoles of hTgCS-terminal peptides were dissolved in 0.1 mL 
of PBS, pH 7.2. Then, 45  μL of 20 mM sulfosuccinimidyl-6-(biotin-amido) 
hexanoate  (EZ-Link®  Sulfo-NHS-LC-Biotin,  Pierce)  were  added  to  each 
sample (biotin:peptide molar ratio = 6:1), and mixtures were kept on ice for 2 
h. Products were filtered on a 1.5-by-100-cm P2 column in 10 mM NH4HCO3, 
in order to remove unreacted biotin. 2-mL fractions were monitored at 220 nm 
and peaks were pooled and liophylized. Samples were assayed with the Lowry 
protein assay. Liophylized, biotinylated hTgCS-terminal peptides, resuspended 
in 0,5 ml 0,1 M sodium acetate, was oxidated by using 0,5 ml 20mM sodium 
metaperiodate in the dark on ice for 30 minutes. Products were filtered on a 
1.5-by-100-cm P2 column in 33 mM PBS 50 mM NaCl pH 7,2, in order to 
remove the excess of sodium metaperiodate. 1-mL fractions were monitored at 
220 nm and peaks were liophylized to 3 ml. After oxidation, biotinylated hTg 
CS was cross-linked with 150 μl of 50 mM p-Azidobenzoyl hydrazid (ABH) 
photoactivatable  (Pierce)  in  DMSO  for  2  hour  in  the  dark  at  ambient 
temperature. Products were filtered on a 1.5-by-100-cm P2 column in 33 mM 
PBS 50 mM NaCl pH 7,2, in order to remove the excess of  p-Azidobenzoyl 
hydrazid. 1-mL fractions were monitored at 220 nm and peaks were pooled and 
liophylized.
3.3 Experimental animals
All experiments were conducted using groups of five female, 4-week-
old  CBA/J(H-2k)  and  SJL  mice  genetically  susceptible  to  EAT  induction, 
purchased from Jackson laboratories (Bar Harbor, ME). 
3.4 EAT induction
Experimental groups of five female, SJL (H-2s) and CBA/J(H-2k) mice 
were immunized at day 0 with 100 micrograms of hTgCS0, hTgCS (positive 
controls) and PBS (negative controls) in Freund's complete adjuvant (CFA), 
containing 3.5 µg/mL of Mycobacterium tuberculosis, in 50 μl of PBS, in the 
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dorsal thoracic region. On day 7, all animals were given a supplemental dose of 
50 μg of the respective immunogen in 25 μl of PBS, emulsionated with the 
same volume of incomplete Freund’s adjuvant (IFA). After 30 days, mice were 
sacrificed by excess anesthesia, and blood, spleens and thyroids immediately 
collected.  Moreover,  groups  of  five  famale  4-week-old  SJL(H-2s)  and 
CBA/J(H-2k)  were immunized with hTg, hTgCS0 or hTgCS and the selective 
mGluR4  enhancer  (N-fenil-7-idroxyamincyclopropan[b]cromen-carboxamide 
[PHCCC] Tocris Cockson Bristol,  UK). PHCC was dissolved in sesame oil 
(vehicle) and administrated daily to the experimental groups at the dose of 0,03 
- 0,3 - 3 - 300  mg\kg-1.  After 21 days, the mice  were sacrificed by excess 
anesthesia, and blood, spleens and thyroids immediately collected. 
3.5 Evaluation of EAT 
Thyroids  were fixed,  sliced  and stained with May-Grünwald-Giemsa 
for histological examination, or embedded in paraffin for immunoistochemical 
characterization.  Mononuclear  infiltration  of  the  thyroid  was  evaluated 
histologically, according to Verginis et al. (2002), in at least 30 sections per 
thyroid lobe per animal, and scored as follows: 0 = no infiltration; 1 = small 
interstitial accumulation between two or more follicles; 2 = one or two foci of 
inflammatory cells more than the size of one follicle; 3 = 10-40% of field area 
occupied by inflammatory cells; 4 = 40-80% of field area infiltrated.
3.6 Assay of T4 and T3 in mice sera
The concentrations of fT4 and fT3 in mice sera were determined on 10-
100 µL-aliquots  of  sera,  using solid-phase  radio-immunometric  assays 
(Medical Systems), with reference curves of 0.3-7.7 pmol for T4, and 30-920 
fmol for T3.
3.7 Secondary proliferative and secretory responses of splenocytes in 
vitro
Murine  spleens  were  collected  in  5  mL  of  RPMI  1640  medium, 
containing Na pyruvate, L-glutamine, penicillin and streptomycin. Splenocytes 
were obtained by mechanical disruption of spleens with the upper extremity of 
a disposable syringe plunger and transferred into sterile 50 mL Falcon tubes. In 
order  to  remove red cells  and dead cells,  spleen  cells  were  layered  onto  a 
cushion  of  Lympholyte-M  (Cedarlane)  and  centrifuged  at  1000  g for  20 
minutes. Live cells were carefully collected at the interface with Lympholyte-
M,  transferred  to  new tubes  and  resuspended  by the  addition  of  5  mL of 
medium,  diluted  1:100  with  PBS  and  counted  in  a  Burker’s  cell. After 
centrifugation, medium was aspirated and cells were resuspended in complete 
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RPMI 1640 medium, containing 2% fetal bovine serum (FBS), so to obtain a 
cell density of 2.5 x 106 cells/mL. 200 µL aliquots of cell suspension (5 x 105 
cells/100µL/well) were cultured for proliferation assays in flat-bottom 96-well 
plates and incubated at 37°C, in a 5% CO2/90% air-humidified incubator in the 
absence or presence of graded doses (30 µg) of hTgCS0 or hTgCS, or purified 
hTgCSgp  glycopeptide.  After  48  h  of  incubation,  50-µL  aliquots  of 
supernatants were removed from each well for cytokine assay.  1 μCi of [3H]-
thymidine was added to each well  and incubation prolonged for 16 h,  after 
which the cells were blotted onto glass-fiber filters and radioactivity counted in 
beta  counter.  Same  procedure  was  adoptetd  in  the  mice  CBA/J  and  SJL 
immunized with antigens hTg, hTgCS0, hTgCS and treated with PHCC.  All 
assays were performed in triplicate and results were expressed as Stimulation 
Index (S.I.), defined as follows: cpm in the presence of antigen/cpm in the 
absence  of  antigen.  The  concentrations  cytokines in  the  supernatants  of 
splenocyte  proliferative  reactions  were  measured,  using  a  multiparametric 
bead-based flow-cytometric Analyte Detection System  (FlowCytomix Mouse 
TH1/TH2 10plex, Bender MedSystems®). Measurements were performed using 
a Dako flow cytometer.
3.8 Serum antibody assays
Total  IgG,  IgG1,  IgG2a and IgG3 concentrations  in  mice  sera  were 
measured  by ELISA assay in  96-well  plates  coated  with  1  µg  of  hTgCS0, 
hTgCS  or  hTgCSgp  as  the  capture  antigen.  IgG  were  assayed  on  1:6000 
dilutions  of  sera,  using  biotinylated  goat  anti-Ig  γ chain  F(ab’)2 secondary 
antibodies. IgG1, IgG2a and IgG3 were assayed on 1:20000, 1:500 and 1:500 
dilutions of sera,  respectively,  using biotinylated rat  monoclonal  anti-mouse 
IgG1, IgG2a and IgG3 antibodies (LO-MG1,  LO-MG2a and LO-MG3 clones, 
Sigma). Detection was performed with streptavidine-peroxidase conjugates and 
orthophenylenediamine.
3.9 Isolation of murine CD4+ cells
The purification of CD4+ T lymphocytes was performed with the MACS 
CD4 isolation  kit  (Miltenyi  Biotec).  The cell  mixture  derived from splenic 
tissue  in  RPMI  supplemented  with  2  % FBS  at  a  cell  density  of  2.5x106 
cells/ml, was centrifuged for 10 minutes at a speed of 300 rcf. The supernatant 
was removed and the pellet resuspended in 15 ml falcon with PBS pH 7.2, 0.5 
% BSA , 2 mM EDTA (buffer A), at a dilution of cell 107 cells/40 μl at 4 °C. 10 
μl of a mixture of monoclonal antibodies biotinylated directed against CD8a 
(Ly -2) (rat IgG2a), CD11b (Mac -1) (rat IgG2b), CD45R (B220) (rat IgG2a), 
DX5 (rat IgM) and Ter -119 (rat IgG2b) (Biotin- Antibody Cocktail, No. 130-
090-860 , Miltenyi Biotec) were added to each 107  cells. The reaction mixture 
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was incubated for 10 minutes at 4-8 °C. Subsequently were added 30  μl of 
buffer A and 20 μl of antibody monoclonal anti-biotin bound to magnetic beads 
(Anti -Biotin Microbeads , No. 130-090-860 , Miltenyi Biotec ), incubating for 
15  minutes  at  4-8  °C.  After  two  washes  with  buffer  A,  the  pellet  was 
resuspended in 500 μl of the same buffer for a dilution of 2x108 cells/ml. The 
separation of CD4+ lymphocytes was completed using a column LS MACS 
(Miltenyi Biotec , No. 130-042-201) equilibrated with buffer A. The column 
was placed in a magnetic field in this way all non CD4+cells were retained, 
while the CD4+ lymphocytes were eluted and collected in tubes collectors (MS 
columns plus tubes , No. 130-041-301 Miltenyi Biotec).
3.10 Secondary proliferative and secretory responses of lymphocytes 
CD4+ in vitro
Secondary proliferative and secretory responses of lymphocytes CD4+ 
in vitro experiments were performed as indicate in secondary proliferative and 
secretory responses of splenocytes in vitro experiments previously described.
 
3.11 Cross-linking of hTgCSgp to T cells receptors and Western blot
24 μg of hTgCSgp biotinylated and conjugated with ABH, was diluted 
to a final volume of 3.0 ml with pyrogen-free water, 365 μl of his solution (~ 3 
g) were added to the 6-well  plate containing the isolated CD4+ T cells  (107 
cells/well). After incubation for 30 minut-es at 37 °C each culture medium, was 
transferred  to  run  the  washing  procedure  for  the  elimination  of  excess 
hTgCSgp - ABH not bound. The washing was performed by centrifugation at a 
speed of 1600 rpm for 5 min, at the end of centrifugation, the supernatant was 
removed and the pellet resuspended in serum-free medium. Finally the cells 
were transferred into a 6-well culture plate and irradiated with a UV lamp to a 
length wavelength of 365 nm, in the dark, for 15 minutes. After irradiation, the 
cells  were  centrifuged  at  1600  rpm  for  5  minutes,  the  supernatant  was
removed and the pellet resuspended in 5 ml of sterile D-PBS. This solution 
were collected :
1. 10 μl for the treatment with 4 % paraformaldehyde (PFA), to perform 
the confocal microscopy.
2. 4.80 ml were used to prepare the cell lysate.
Cells were lyseted in 0.5 ml of lysis buffer (50 mM Tris/HCl pH 7.4 , 150 mM 
NaCl, 5 mM EDTA, 1 % Nonidet P-40, 1 mM sodium orthovanadate and 1 X 
Mix Antiprotease) and centrifuged at a speed of 10,000 rcf for 10 minutes. The 
supernatant was transferred in conical tubes centrifuge on ice. 100-200 μg of 
total cell lysate were immunoprecipitated by adding ~ 0.4 μg of primary anti-
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biotin antibody (Biotin-39 15D9: sc-57636) 1 h  at 4 °C then, 20 μl of Protein 
A/G PLUS-Agarose (Santa Cruz Biotechnology, INC. SC-2003). Sample was 
incubated O.N. at 4 °C with shaking on a shaker rotating plate vertical. After 3 
wash at 1000 rcf for 5 minutes at 4 °C with PBS, the immunoprecipitate were 
resuspended in  40  μl  of  Laemmli  1X for  the  SDS-PAGE and western  blot 
analisis.
The SDS-PAGE was performed as described by Leammeli (Leammeli, 1970), 
setting up a gradient of 8-18 % acrylamide in buffer 0.375 M Tris/Hcl pH 8.8, 
0.1% SDS, and using an electrophoretic Amersham sistem. The electrophoresis 
was conducted at 10 mA for 16 hours.The western blot was performed with a 
semi-dry blotting  American Bionetics  (model  SDB -1000) using  as  transfer 
buffer  25  mM Tris  base  and  10  mM glycine,  at  a  constant  current  of  0.8 
mA/cm 2 for 90 minutes.  Blotted Immobilon-P membranes (Millipore)  was 
blocked with PBS-Tween-Milk for 60 minutes at room temperature (PBS pH 
7.5,  0.2 % Tween-20, 5% Milk powder Bio-Rad).  Immobilon-P membranes 
was washed 3 times with PBS-Tween and incubated O.N. at 4 °C with  the 
monoclonal primary antibody anti -biotin (Biotin - 39 15D9 : sc- 57636) in a 
ratio of 1/100 (v/v) of PBS -Tween, 3 %BSA. Finally, after 3 wash wih PBS-
Tween, immobilon-P membranes was incubated with secondary antibody anti-
mouse IgG HRP (horseradish peroxidase) conjugate, in relation 1/20.000 (v/v) 
with PBS Tween, 3% BSA followed by washing. Immunoreactive bands were 
visualized with ECL Plus (GE Healthcare).
3.12 Confocal microscopy
The cells (2x104) were spread on a glass slide, fixed for 15 minutes in 
4% formaldehyde, washed twice with PBS, permeabilized with 1% Triton X-
100  for  30  minutes  at  room  temperature  and  washed  again  with  PBS. 
Subsequently the slides were incubated with 1% BSA in PBS for 30 minutes at 
room temperature,  after  which,  were incubated ON with primary antibodies 
anti-biotin and anti-CD44 (1/100 in 1% BSA dissolved in PBS) at 4 °C. The 
slides were washed, and incubated for 60 minutes at room temperature with 
secondary antibodies conjugated with fluorochromes, phycoerythrin (PE) for 
anti-biotin and fluorescein isothiocyanate (FITC) for anti-CD44 (1/100 in 0.1% 
BSA dissolved in PBS), washed again and mounted with a coverslip. The slides 
were examined under a Leica TCS SP2 confocal microscope equipped with an
objective to water immersion HCX Apo 0.8.
3.13 Statistical analysis
Data  are  expressed  as  mean  ±  SD,  unless  otherwise  specified.  The 
statistical  significance  between  data  obtained  in  experiments  of  splenocyte, 
lymphocytes  proliferations,  cytokine  assas  and  serum  immunoglobulin 
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concentrations was determined by t paired or two-tailed Mann-Withney test, as 
indicated.  A value of  p  <0.05 was considered to  be statistically significant. 
Hystological  evaluation  of  thyroid  infiltration  was  analyzed  by  the  non-
parametric rank-sum Wilcoxon test.
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4. RESULTS 
4.1. hTgCS is a stronger inducer of EAT compared with hTgCS0 in 
CBA/J(H-2k) mice
In order to evaluate the ability of hTgCS0 and hTgCS to induce EAT in 
genetically  susceptible  CBA-/J(H-2k)  mice,  two  groups  of  experimental 
animals were immunized subcutaneously with the respective immunogens in 
complete  (sensitization)  and  incomplete  (boosting)  Freund's  adjuvant. 
Immunization  with  hTgCS  resulted  in  the  induction  of  a  more  severe 
thyroiditis than immunization with hTgCS0, as judged from histopathological 
and biochemical indices of thyroid organ disease.
Figure 4 and Table 1 show the average disease scores assigned to 61 
mice in 4 immunization experiments, by the histological examination of 25-30 
seriate tissue sections per thyroid lobe per animal. The large majority of scores 
2  and  all  scores  3,  corresponding,  respectively,  to  one  or  more  foci  of 
infiltration more than the size of a thyroid follicle, and 10-40% of field area 
occupied by mononuclear cells, were assigned to mice immunized with hTgCS. 
In contrast, mice immunized with hTgCS0 were either unaffected or showed 
very limited thyroid involvement. 
Fig. 4. Histological EAT score, indicating the extent of mononuclear cell infiltration of the 
thyroid glands of CBA/J(H-2k) mice immunized with the two different forms of hTg.  EAT 
score was calculated in accordance with the criteria  by Verginis et al. (2002) infiltration; 1 = 
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limited interstitial infiltration of mononuclear cells between two or more follicles; 2 = one or  
two foci of infiltrating mononuclear cells more than the medium size of one follicle; 3 = 10-
40% of field area occupied by infiltrating cells; 4 = 40-80% of field area infiltrated.
Table 1. Number and percent of CBA/J(H-2k) mice assigned disease scores from 0 to 4 in four 
different immunization experiments with hTgCS0 and hTgCS. For score codes,  refer to the 
legend to Figure 1.
Immunizing 
agent
Score 0 Score 1 Score 2 Score 3 Number of 
mice
PBS 57,69% 41,31% 0% 0% 13
TgCS0 56,25% 39,58% 4,17% 0% 24
TgCS 6,25% 54,17% 29,17% 10,42% 24
Figure 5 shows a typical aspect of thyroid infiltration with mononuclear 
cells in EAT, distinctly more marked in CBA/J mice immunized with hTgCS 
(score 3), compared with mice immunized with hTgCS0 (score 1).
Fig.  5.  Representative aspects  of  thyroid mononuclear infiltration in EAT.  The thyroid 
section shown in A3 was obtained from a CBA/J(H-2k) mouse immunized with hTgCS and was 
assigned score 3, while the section shown in A2 was from a mouse immunized with hTgCS0 
(score 1). A normally appearing thyroid section from a control animal is shown in A1 (score 0).
The  increased  severity  of  thyroid  tissue  involvement  detected  by 
histological examination was reflected in the increases in serum concentrations 
of  3,5,3',5'-tetraiodothyronine  (T4)  and  3,5,3'-triiodothyronine  (T3),  which 
were significantly different  in  mice immunized with hTgCS, in comparison 
with both control mice and  mice immunized with hTgCS0.
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Fig.  6.  Serum  concentrations  of  T3  (3,5,5’-triiodothyronine)  and  T4  (thyroxine)  of 
CBA/J(H-2k) mice immunized with hTgCS0 or hTgCS. Results are expressed as means ± 
S.D. * indicates the statistical significance between hTgCS and both mice groups immunized 
with PBS (negative control) and hTgCS0 (p <0,05).
 We have shown that hTg is regularly composed of a mixture of hTgCS0 
and hTgCS, in variable proportions among different individuals.  From the data 
here reported, it appears that the induction of autoimmune thyroid disease in 
experimental  animals  depends  prevailingly  on  the  hTgCS  fraction  of  hTg. 
Because investigators of EAT have been using so far unfractionated hTg for 
their  experiments,  it  appears  that  the  variable  severity  of  EAT observed  in 
many studies was  influenced by the composition of the  hTg preparations used. 
Moreover,  the relative proportion  of  heterodimeric  and homodimeric 
hTgCS and the average chain length of the chondroitin 6-sulfate chain linked to 
hTg might influence EAT severity. Further studies in regard are warranted.
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4.2 hTgCS is more effective than hTgCS0 in promoting the primary 
sensitization in vivo of murine splenic lymphocytes to shared 
epitopes of  hTgCS0 and hTgCS
Secondary proliferative assays were performed  in vitro  by stimulating 
murine  splenocytes  with  hTgCS0 and  hTgCS.  Proliferative  responses  were 
markedly higher in mice immunized with hTgCS than in mice immunized with 
hTgCS0.  On  the  other  hand,  the  splenocytes  from  both  groups  exhibited 
responses of comparable magnitude to both forms of hTg, i.e.,  hTgCS0 and 
hTgCS,  even  though  the  responses  to  hTgCS0 were  blunted  at  the  highest 
doses,  whereas  those  to  hTgCS  kept  increasing  with  the  dose  (Figure  7). 
Overall, these results clearly indicate that the differences in immunopathogenic 
potential  between hTgCS0 and hTgCS reside in the greater ability of hTgCS to 
promote the primary sensitization of murine T cells to shared epitopes between 
hTgCS0 and hTgCS, these being, in turn, also shared between hTg and murine 
Tg  (Simon et  al.,  1986).  These epitopes  are  most  likely of  peptidic  nature, 
whereas the chondroitin 6-sulfate oligosaccharide unit of hTgCS appears to be 
acting as a promoter of the breaking of tolerance to these epitopes, without 
being an immunopathogenic epitopes of its own.
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Fig. 7. Proliferative responses of splenic lymphocytes from CBA/J(H-2k) mice immunized 
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and restimulated in vitro with the two forms of hTg. Mice were immunized with  hTgCS0 or 
hTgCS in CFA, as described in the Methods. Splenic lymphocytes were restimulated in vitro  
with both antigens, at the doses indicated. Results are expressed as means ± S.D.
4.3 Enzymatic dechondroitination deprives hTgCS of its enhanced 
ability to sensitize murine lymphocytes to shared hTg epitopes
To prove the role of the CS oligosaccharide unit of hTg in the observed 
increased  ability  of  hTgCS  to  promote  the  sensitization  in  vivo and  the 
proliferative  responses  in  vitro  of  murine  T  cells  to  shared  antigenic 
determinants of hTgCS0 and hTgCS, we determined the proliferation indices of 
splenocytes  from  mice  immunized  with  hTg  subjected  to  enzymatic 
dechondroitination with ABC chondroitinase from Proteus vulgaris(hTgCSde), 
restimulated  with  the  various  forms  of  hTg.  As  shown  in  Figure  8,  the 
proliferation  indices  obtained  in  mice  immunized  with  hTgCSde  upon 
restimulation with hTgCS0, hTgCS and hTgCSde were similar to the responses 
obtained  in  mice  immunized  with  hTgCS0,  paralleling  those  observed  in 
negative  control  mice.  On  the  other  hand,  the  splenocytes  from  mice 
immunized with hTgCS proliferated in  response to  hTgCSde,  with a similar 
pattern as observed with hTgCS0, in that both responses tapered down as the 
dose  of  the  test  antigen  increased,  whereas  the  responses  to  hTgCS  kept 
increasing with the dose. These results indicate that the differences observed in 
the proliferative responses of splenocytes from mice immunized with hTgCS0 
and hTgCS were solely dependent upon the CS oligosaccharide unit of hTgCS.
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Fig. 8. Proliferative responses of splenic lymphocytes from CBA/J(H-2k) mice immunized 
and restimulated in vitro with hTgCS0, hTgCS and enzymatically dechondroitinated hTg 
(hTgCSde): Mice were immunized with  hTgCS0, hTgCS or hTgCSde in CFA, as described in 
the Methods. Splenic lymphocytes were restimulated in vitro with each of the three antigens, at 
the doses indicated. Results are expressed as means ± S.D.
4.4 Chondroitinated nonapeptide hTgCSgp isolated from hTgCS 
displays mitogenic activity towards naïve and hTg-sensitized 
murine splenic lymphocytes
Next, we investigated whether the improved mitogenic ability exhibited 
by hTgCS, especially at high doses, in comparison with hTgCS0, in secondary 
proliferative responses of splenic lymphocytes could be actually attributed to 
its  chondroitin  6-sulfate  oligosaccharide  unit.  To  this  aim,  we isolated  and 
purified to  homogeneity the sole  CS oligosaccharide unit  of hTg,  linked to 
Ser2730,  in  the  most  elementary  form  obtainable  with  the  least  possible 
contribution  by  the  polypeptide  mojety  of  hTg,  i.e.,  in  the  form  of  the 
chondroitin sulfate-containing nonapeptide hTgCSgp. The latter was produced 
by the extensive digestion of reduced and alkylated hTgCS with staphylococcal 
V8 protease (endoproteinase Glu-C) and purified to homogeneity, as described 
in  detail  in  the  Methods.  The  results  of  the  restimulation  of  splenic 
lymphocytes  from  mice  immunized  with  PBS,  hTgCS0 and  hTgCS  with 
hTgCSgp are shown in Figure 8. The CS-containing glycopeptide stimulated 
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the proliferation not only of splenocytes from immunized mice, but also from 
negative  control  animals,  at  variance  with  the  homologous  synthetic,  non-
glycosylated hTg peptide 2726-2734, with the LTAGSGLRE sequence, which 
proved ineffective (Figure 9).
Fig. 9. Proliferative responses of splenic lymphocytes from CBA/J(H-2k) mice immunized 
and restimulated in vitro with hTgCS0 or hTgCS and restimulated in vitro with the CS-
copnatining  purified  glycopeptide  hTgCSgp:  Mice  were  immunized  as  described  in  the 
Methods. Splenic lymphocytes were restimulated  in vitro  with 2  μg/mL of the purified CS 
containing glycopeptide hTgCSgp or its synthetic, non-glycosylated homologous nonapeptide 
LTAGSGLRE. Results are expressed as means ± S.D.
4.5 The CS unit of hTg, both as a mojety of hTgCS and in the form of 
hTgCSgp glycopeptide, synergizes CD28-mediated costimulation of 
the proliferation of  CD4+ T cells in response to anti-CD3 Abs
We first investigated the proliferative responses of CD4+ T cells isolated 
from the spleens of CBA/J mice immunized with hTgCS0 or hTgCS to the C6S 
unit of hTg, as a mojety of hTg-CS or in isolated form (hTgCSgp), alone or in 
combination with monoclonal anti-CD3 and anti-CD28 antibodies at optimal 
concentrations  (Figure  10).  Marginal  proliferation  was  observed  in  T cells 
stimulated  with  anti-CD3  alone,  whereas  simultaneous  anti-CD3  and  anti-
CD28 stimulation  in  CD4+ T cells  from negative  control  (PBS-immunized) 
mice and hTg-immunized mice was marked by proliferation indexes around 20 
and 40-45, respectively, as one might expect.
Complementation of the stimulation by anti-CD3 antibodies with the 
addition of hTgCS or hTgCSgp was associated with significant, comparable 
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increases of the proliferation of CD4+ T cells from hTg-immunized mice, more 
marked in those which appeared to have been sensitized more effectively as a 
consequence  of  the  immunization  with  hTgCS  rather  than  with  hTgCS0. 
Limited  proliferative  responses,  with  a  similar  pattern  as  just  described, 
followed the administration of hTgCS and hTgCSgp, even in the absence of 
anti-CD3 antibodies,  and  may reflect  a  TCR-independent,  although  limited 
mitogenic potential of CS in activated CD4+ T cells. Such effects of hTgCS 
were replicated by hTgCSgp, but not by hTgCS0 and were not seen with CD4+ 
T  cells  from  negative  control  animals.  Compared  with  the  costimulation 
afforded  by  anti-CD28  in  addition  to  anti-CD3  antibodies  at  optimal 
concentration,  the costimulation provided by hTgCS or hTgCSgp alone was 
partial, more so in hTgCS0-immunized mice than in hTgCS-immunized mice. 
Notably,  at  variance  with  CS-dependent  costimulation,  CD28-mediated 
costimulation induced the proliferation of CD4+ T cells not only from hTg-
immunized mice, but also from negative control animals (likely reflecting the 
novel sensitization of naïve T cells), even though to a smaller extent. However, 
in  hTg-immunized  mice,  the  costimulation  afforded  by  the  CS  unit  was 
additive (see the effect  of hTgCS) or  actively synergistic  (see the effect  of 
hTgCSgp)  with  CD28-mediated  costimulation,  particularly in  CD4+ T cells 
from hTgCS-immunized mice.
Fig  10.  Secondary  proliferative  responses  of  CD4+ T  cells  isolated  from  splenic 
lymphocytes from CBA/J mice immunized with hTgCS0 or hTgCS and restimulated  in  
vitro  with hTgCS0.  hTgCS or  hTgCSgp, with or without the addition of anti-CD3 and 
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anti-CD3/CD28  antibodies. Test  antigen  concentrations  were:  50  μg/mL for  hTgCS  and 
hTgCS0, 1.15 μg/mL for hTgCSgp. Results are expressed as means ± S.E.M.
4.6 Cytokine  secretion  patterns  in  secondary  responses  of  isolated 
murine CD4+ T cells reveal the costimulatory role of the CS unit of 
hTg and its variable impact on the differentiation and phenotypic 
expression of distinct TH cell subsets
IL-2  secretion  (Figure  11)  was  elicited  in  positive  controls  by  the 
combined addition of anti-CD3 and anti-CD28 antibodies,  as expected.  The 
comparable levels of the IL-2 secretory responses of negative control mice and 
hTg-immunized mice suggests that the T cells responsible for the observed IL-
2 production were mostly naïve T cells, in keeping with the role played by IL-2 
production in the early phase of TH0 differentiation. Accordingly, the study of 
IL-2 production might permit us to gain some insight into the role played by 
the CS unit of hTg in the de novo sensitization of CD4+ T cells, even within the 
context of secondary proliferative responses. The CS unit, both as a mojety of 
hTgCS and in isolated form (hTgCSgp), was unable to elicit IL-2 secretion, 
either  by  itself  or  in  combination  with  anti-CD3  antibodies.  However,  the 
addition of the hTgCS or, to an even larger extent, the addition of hTgCSgp, to 
anti-CD3/CD28-stimulated  CD4+ T  cells  was  accompanied  by  marked 
increases  of  IL-2  secretion.  This  is  reminiscent  of  what  was  reported  by 
Galandrini et al. in 1993 for the interaction of hyaluronic acid (HA) with CD44 
and suggests that the costimulatory effects of the CS unit on IL-2 production 
were accessory with respect to the costimulatory action of CD28 and someway 
dependent upon it (Galandrini et al., 1993). This, in turn, may imply that also 
the effects of the CS unit on CD4+ T cell proliferation described above (see 
paragraph 4.5) were complex and included: a) effects upon the proliferation of 
de novo sensitized hTg-specific naïve CD4+ T cells, which the CS unit was able 
to  exert  only  conditionally,  by  enhancing  the  effects  of  CD28-mediated 
costimulation;  b)  effects  upon  the  re-expansion  of  hTg-specific,  effector 
memory  CD4+ T  cells,  which  the  CS  unit  was  able  to  exert  in  a  CD28-
independent way, by activating the expression of typical phenotypic markers of 
definite  TH cell  subsets,  starting from the secretion of cytokines caoable of 
sustaining  such re-expansion.  The data  that  follow will  show how,  in  turn, 
some of these effects were also independent of the stimulation of TCR, like the 
secretion  of   IFN-γ and  TNF-α by  TH1  cells,  whereas  other  effects  were 
dependent upon it, like the secretion of IL-17 by TH17 cells. 
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Fig 11. IL-2 secretion in the media of secondary proliferative responses of  CD4+ T cells 
isolated from splenic lymphocytes from CBA/J mice immunized with hTgCS0 or hTgCS 
and restimulated  in vitro  with hTgCS0. hTgCS or  hTgCSgp, with or without anti-CD3 
and anti-CD3/CD28 antibodies. Test antigen concentrations were: 50 μg/mL for hTgCS and 
hTgCS0, 1.15 μg/mL for hTgCSgp. Results are expressed as means ± S.E.M.
Stimulation with the CS unit, either in the form of hTgCS or hTgCSgp, 
elicited significant IFN-γ (Figure 12) secretion in CD4+ T cells from hTgCS-
immunized  mice,  and  minor  secretory  responses  in  hTgCS0-immunized 
animals.  The  addition  of  anti-CD3  antibodies  to  hTgCS  or  hTgCSgp  had 
statistically non-significant additive effects. Instead,  costimulation with anti-
CD3/CD28  antibodies,  in  addition  to  the  CS  unit,  elicited  significant, 
proportional  increases  of  IFN-γ  secretion  by  CD4+ T  cells  not  only  from 
immunized  mice,  but  also  from  negative  control  mice.  Notably,  CD28-
mediated costimulation appeared to be conditional for the expression of the 
IFN-γ secretory ability by CD4+ T cells from control mice, likely reflecting the 
TH1 differentiation of  de novo sensitized hTg-reactive CD4+ T cells. Instead, 
hTgCS  and,  to  a  larger  extent,  hTgCSgp  exhibited  the   ability  to  elicit 
significant IFN-γ secretion by the CD4+ T cells of hTgCS-immunized mice and 
minor responses by the CD4+ T cells of hTgCS0-immunized mice, independent 
of any adjunct stimulation, even of the TCR. Also, the addition of the CS unit, 
particularly in the form of hTgCSgp, effectively synergized CD28-mediated 
costimulation of newly sensitized CD4+ T cells from negative control animals. 
Thus, the large increases of IFN-γ secretion observed with CD4+ T cells from 
hTgCS0- and, to a larger extent, from hTgCS-immunized mice, likely reflected 
a combination of: 1) the independent action of the CS unit on the expression of 
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the IFN-γ secretory ability by hTg-reactive effector TH1 cells (especially those 
more  effectively  sensitized  via  the  immunization  with  hTgCS);  2)  the 
synergysm between CS-dependent and CD28-mediated costimulation in the de 
novo sensitization of naïve hTg-reactive CD4+ T cells.
The data reported above seem to indicate that IFN-γ secretion by naïve 
CD4+ T cells was strictly dependent, like proliferation, upon CD28-mediated 
costimulation,  which  could  be  enhanced,  but  not  substituted  for  by  CS-
dependent  costimulation.  In  contrast,  CS-dependent  stimulation  was 
absollutely  required  and  sufficient  for  hTg-reactive  effector  TH1  cells  to 
express their IFN-γ secretory ability (a typical marker of the TH1 differentiated 
phenotype), even in the absence of anti-CD3-mediated TCR stimulation.  This 
is  reminiscent  of  what  was  observed  in  experimental  autoimmune 
encephalomyelitis (Guan et al., 2011).
Fig 12. IFN-γ secretion in the media of secondary proliferative responses of CD4+ T cells 
isolated from splenic lymphocytes from CBA/J mice immunized with hTgCS0 or hTgCS 
and restimulated  in vitro  with hTgCS0. hTgCS or  hTgCSgp, with or without anti-CD3 
and anti-CD3/CD28 antibodies. Test antigen concentrations were: 50 μg/mL for hTgCS and 
hTgCS0, 1.15 μg/mL for hTgCSgp. Results are expressed as means ± S.E.M.
TNF-α secretion in response to the CS unit,  alone or in combination 
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with anti-CD3/CD28 antibodies, conformed to a similar overall pattern as just 
described for IFN-γ.  However,  the secretory activity of naïve CD4+ T cells 
from control mice, whose  de novo  sensitization appeared to be dependent on 
CD28-mediated costimulation, was minor and the addition of the CS unit did 
not  appear  to  synergize  appreciably  the  effects  of  CD28-mediated 
costimulation on TNF-α secretion in these cells (Figure 13).
 
Fig 13. TNF-α secretion in the media of secondary proliferative responses of CD4+ T cells 
isolated from splenic lymphocytes from CBA/J mice immunized with hTgCS0 or hTgCS 
and restimulated  in vitro  with hTgCS0. hTgCS or  hTgCSgp, with or without anti-CD3 
and anti-CD3/CD28 antibodies. Test antigen concentrations were: 50 μg/mL for hTgCS and 
hTgCS0, 1.15 μg/mL for hTgCSgp. Results are expressed as means ± S.E.M.
The patterns of IL-17 (Figure 14) secretory by isolated CD4+ T cells 
were peculiar in that: a) the combined use of anti-CD3/CD28 antibodies did not 
elicit any detectable secretion of IL-17, not even by naïve CD4+  T cells from 
negative control animals; significant, although minor amounts of IL-17 were 
secreted by the CD4+ T cells of the control group of mice only in response to 
the  combined  administration  of  hTgCS  or  hTgCSgp  and  anti-CD3/CD28 
antibodies; b) with CD4+ T cells from hTgCS-immunized mice, maximal IL-17 
secretion was observed upon combined stimulation with hTgCS or hTgCSgp 
and anti-CD3 antibodies, independent of CD28-mediated costimulation; c) like 
IL-17 secretion by CD4+ T cells from control mice, significant IL-17 secretion 
also  by  poorly  sensitized  CD4+ T  cells  from  hTgCS0-immunized  animals 
required the simultaneous costimulation with anti-CD28 antibodies and CS, in 
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adjunct to TCR stimulation with anti-CD3 antibodies. This seems to indicate 
that hTg-reactive, effector CD4+ T cells effectively sensitized by hTgCS did 
not  have  a  requirement  for  CD28-mediated  costimulation,  other  than 
restimulation  of  their  TCRs.  This  is  in  keeping  with  the  observation  that 
serglycins, small proteoglycans stored in secretory granules of hematopoietic 
cells,  activated the CD3-dependent  release of  cytokines  and proteases  from 
CD44-positive cytotoxic lymphocytic clones (Toyama-Sorimachi et al., 1995) 
by interacting with CD44 through their chondroitin 4-sulfate and 6-sulfate side 
chains  (Toyama-Sorimachi et al.,  1997). Unlike effector CD4+ T cells, hTg-
reactive CD4+ T cells in the naïve status or less effectively sensitized by hTg-
CS0 had complex costimulation requirements for the expression of the TH17 
phenotype  (marked  by  IL-17  secretion),  which  included  the  simultaneous 
costimulation by CS and CD28 ligands. On one hand, with these naïve T cells, 
CS-dependent costimulation seemed to be strictly required, to the same extent 
as and in combination with CD28-mediated costimulation, in order to prompt 
the TH17 differentiation of hTg-specific naïve CD4+ T cells. On the other hand, 
the expression of the TH17 differentiated phenotype by effector memory CD4+ 
T cells had completely different requirements for costimulation with respect to 
naïve cells, being: a) rigorously CS-dependent, but completely independent of 
CD28-mediated costimulation; b) rigorously conditioned to the simultaneous 
TCR engagement.
Fig 14. IL-17 secretion in the media of secondary proliferative responses of CD4+ T cells 
isolated from splenic lymphocytes from CBA/J mice immunized with hTgCS0 or hTgCS 
and restimulated  in vitro  with hTgCS0. hTgCS or  hTgCSgp, with or without anti-CD3 
and anti-CD3/CD28 antibodies. Test antigen concentrations were: 50 μg/mL for hTgCS and 
hTgCS0, 1.15 μg/mL for hTgCSgp. Results are expressed as means ± S.E.M.
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Finally, considerable IL-6 (Figure 15) secretion was evoked by hTgCS 
and, to a larger extent, by hTgCSgp in CD4+ T cells isolated from the spleens 
of mice immunized with hTgCS. Proportionally smaller responses were elicited 
by the same additives in CD4+ T cells from hTgCS0-immunized mice. Such 
responses were totally independent of concomitant CD3- and CD28-mediated 
stimulation and costimulation, respectively. No IL-6 secretion at all was incited 
either  by the CS unit,  or  by anti-CD3/CD28 antibodies in  CD4+ T cells  of 
control mice.
Fig 15. IL-6 secretion in the media of secondary proliferative responses of  CD4+ T cells 
isolated from splenic lymphocytes from CBA/J mice immunized with hTgCS0 or hTgCS 
and restimulated  in vitro  with hTgCS0. hTgCS or  hTgCSgp, with or without anti-CD3 
and anti-CD3/CD28 antibodies. Test antigen concentrations were: 50 μg/mL for hTgCS and 
hTgCS0, 1.15 μg/mL for hTgCSgp. Results are expressed as means ± S.E.M.
4.7 EAT induction in CBA/J(H-2k) and SJL(H-2s) mice is suppressed by 
PHCCC, a selective inhibitor of TH17 cell differentiation
The data reported above indicated that EAT induction in CBA/J(H-2k) 
mice depend prevailingly or solely on the hTgCS fraction of hTg. In particular, 
the CS oligosaccharide unit  of hTgCS played a pivotal role not only in the 
expression of the differentiated phenotype by effector TH1 and TH17 cells, but 
also in the sensitization of hTg-specific CD4+ T cells into armed effector TH 
cells and in the polarization of their differentiation in TH cells of both kinds. In 
particular, the costimulatory action of the CS unit was shown to be accessory 
and synergistic with respect to CD28-mediated costimulation of the  de novo 
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sensitization of  TH1 cells, while being capable of stimulating the phenotypic 
expression of differentiated effector TH1 cells in a CD28-independent manner. 
Instead, CS-dependent costimulation turned out to be as necessary as CD28-
mediated costimulation for the differentiation of TH17 cells, while its ability  to 
stimulate the phenotypic expression of differentiated effector TH17 cells was 
fully CD28-independent, yet strictly dependent upon TCR stimulation by anti-
CD3 antibodies. Therefore, it appears that the CS unit conferred upon hTg a 
quantitative  immunopathogenic  advantage,  as  for  the  differentiation  of  TH1 
effector  cells,  together  with  a  unique  qualitative  advantage,  as  far  as  the 
differentiation of Th17 effector cells was concerned. Thus, it may be expected 
that a selective strategy for inhibiting the differentiation of autoreactive, hTg-
specific  TH17 cells  might suffice to  counteract most  of the enhancement of 
EAT  induction  brought  about  by  hTgCS.  To  this  aim,  we  adopted  an 
experimental  strategy based  upon  the  usage  of  N-phenyl-7-(hydroxyimino)-
cyclopropa[b]chromen-1a-carboxamide (PHCCC). Four groups of mice were 
immunized, respectively,  with PBS, hTgCS0, hTgCS and hTgCS plus PHCCC. 
PHCCC is a selective agonist of metabotropic glutamate receptor 4 (mGluR4) 
enhancer, which was proven to suppress highly effectively the development of 
experimental  autoimmune  encephalomyelitis  (EAE)  in  mice,  by  negatively 
affecting the TH17 differentiation of naïve antigen-specific T cells (Nicoletti et  
al., 2007; Fallarino et al., 2010).
We performed two experiments of this kind in two strains of genetically 
susceptible mice, namely CBA/J(H-2k) and SJL(H-2s) mice. Initial exploratory 
experiments were performed not only with fractionated hTgCS0 and hTgCS, 
but  also  with  unfractionated  hTg  (hTg),  which  contains  both. The  daily 
administration of PHCCC to mice of bith strains immunized with hTg for the 
entire period preceding sacrifice was associated with the development of a very 
mild   autoimmune  thyroiditis,  in  comparison  with  the  more  severe  disease 
which  developed in  mice  immunized with  hTg alone.  Also  the  histological 
disease scores recorded in experimental animals immunized with hTgCS were 
distinctly  higher  than  those  recorded  in  mice  immunized  with  hTgCS,  in 
association with the treatment with PHCCC (Figure 16-17). In addition, the 
average  histological  scores  detected  in  mice  immunized  with  hTgCS  plus 
PHCCC were similar to the average disease scores detected in mice immunized 
with hTgCS0. These evidences indirectly confirmed the essential costimolatory 
role played by the CS oligosaccharide unit of hTg  in the induction of the TH17 
differentiation of hTg-specific CD4+ T cells, and the strict requirement for such 
subset of autoreactive TH cells for the development of EAT.
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Fig 16. Histological EAT scores, indicating the extent of mononuclear cell infiltration of  
the thyroid glands of CBA/J(H-2k) and SJL(H-2s)  mice immunized with unfractionated 
hTg,  with or without added treatment with PHCCC.  The EAT score was calculated in 
accordance with Verginis et al. (2002). Negative control mice were immunized with PBS only.
Fig 17. Histological EAT score, indicating the extent of mononuclear cell infiltration of 
the  thyroid  glands  of  CBA/J(H-2k)  mice  immunized  with  hTgCS0 or hTgCS,  with  or 
without added treatment with PHCCC.  The EAT score was calculated in accordance with 
Verginis et al. (2002). Negative control mice were immunized with PBS only.
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Figure  18  shows  typical  aspects  of  thyroid  infiltration  with 
mononuclear cells, distinctly more marked in both CBA/J(H-2k) mice (score 2) 
and SJL(H-2s)  mice  (score  3)  immunized  with  hTg, compared  with  mice 
immunized  with  hTg  with  added  PHCCC  treatment  (score  1).  Figure  19, 
instead,  shows the  contrast  between the  milder  and more  severe  thyroiditis 
which  developed in  CBA/J  mice  after  immunization  with  hTgCS with  and 
without added PHCCC treatment, respectively, and the similarity between the 
milder diseases ensuing either the immunization with hTgCS0, or with hTgCS 
plus PHCCC treartment.
Fig. 18. Representative aspects of thyroid mononuclear infiltration in EAT.  The thyroid 
section shown  in A2 was obtained from a  SJL(H-2s) mouse immunized with hTg and was 
assigned score 4, while the section shown in A3 was from a SJL(H-2s) mouse immunized with 
hTg and also treated with PHCCC (score 1). A normally appearing thyroid section from a 
control animal is shown in A1 (score 0). The thyroid section shown in B2 was obtained from a 
CBA/J(H-2k)  mouse  immunized  with  hTg (score  3),  while  the  section  in  B3  was  from a 
CBA/J(H-2k) mouse immunized with hTg, which also received PHCCC treatment (score 1), 
normally appearing thyroid section from a control animal is shown in B1 (score 0).
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Fig. 19. Representative aspects of thyroid mononuclear infiltration in EAT.  The thyroid 
section shown in A2 was obtained from a CBA/J(H-2k) mouse immunized with hTgCS0 (score 
1), while the section in A3 was from a CBA/J(H-2k) mouse immunized with hTgCS. Instead, 
the section in A4 was from a CBA/J(H-2k) mouse immunized with hTgCS, which also received 
PHCCC treatment (score 1). A normally appearing thyroid section from a control animal is 
shown in A1 (score 0).
The  decreased  severity  of  thyroid  tissue  infiltration  and  destruction 
detected by histology in CBA/J mice receiving pHCCC treatment throughout 
immunization with  hTg was reflected in  the lower serum concentrations  of 
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3,5,3',5'-tetraiodothyronine (T4) and 3,5,3'-triiodothyronine (T3). These were 
significantly higher  in  mice immunized with hTg,  in  comparison  both with 
control mice and with mice immunized with hTg plus PHCCC (Figure 20).
Fig. 20. Serum concentrations of T3 (3,5,5’-triiodothyronine) and T4 (thyroxine) in the 
sera  of  CBA/J(H-2k)  mice  immunized  with  hTg  and  hTg  plus  PHCCC.  Results  are 
expressed as means ± S.D. * indicates the statistical significance between hTg and each of the 
control and hTg plus PHCCC condition (p <0,05).
4.8 Treatment with PHCCC does not abolish secondary proliferation 
of CD4+ T cells from SJL mice in vitro in response to hTgCS0 and 
hTgCS
Secondary assays of splenocyte proliferation in vitro were performed with the 
splenocytes  of  both  susceptible  mice  strains  immunized  with PBS,  hTg  or 
hTgCS plus or minus PHCCC and restimulated in vitro, after sacrifice, with the 
same antigens. Figure 21 shows the results obtained in SJL mice immunized 
with hTg. Similar results were obtained also in CBA/J mice (data not shown). 
Cpm  counts  (reflecting  the  incorporation  of  [3H]-thymidine)  reached  high 
levels in both groups of mice immunized with hTg and hTg plus PHCCC, in 
comparison with negative control mice immunized with PBS only. This result 
indicated that both groups of mice immunized with hTg and hTg plus PHCCC 
were effectively sensitized  against  hTg.  Nonetheless,  mice  immunized with 
hTg  plus PHCCC did not develop thyroid organ disease, as detected by the 
histological scoring of EAT (Figure 19). 
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Fig.  21  Proliferative  responses  of  splenic  lymphocytes  from  CBA/J(H-2k)  mice 
immunized with  hTg, without or with added PHCCC treatment, and restimulated  in 
vitro with hTg. Mice were immunized and PHCCC treatment was conducted as detailed in the 
Methods.  Negative  controls  received  PBS only.  On day 30,  mice  were  sacrificed,  spleens 
removed  and  splenocytes  were  restimulated  with  the  indicated  doses  of  hTg.  Anti-CD3 
antibodies were used as positive controls. Results are expressed as means ± S.D.
4.9 Cytokine secretion patterns in secondary proliferations of splenic 
lymphocytes from mice immunized with hTg with added PHCCC 
treatment reveal a selective impairment of Th17 cell differentiation
In order to evaluate the effects of the treatment with PHCCC on the 
polarization of TH cell differentiation, the concentrations of IL-2, INFγ, IL-6 
and IL-6,  IL-17  and  were  measured  in  the  supernatants  of  the  secondary 
proliferations of splenic lymphocytes from CBA/J(H-2k) mice immunized with 
hTg, with or without added treatment with PHCCC (Figure 22). As shown in 
figure 18,, IL-2 and IFN-γ were produced at  comparably high levels in the 
supernatants of splenocytes from CBA/J mice immunized with hTg, both with 
and without the addition of PHCCC treatment, whereas they were lacking in 
negative control mice. In contrast, high levels of IL-6 and IL-17 were detected 
only in the supernatants of splenocytes from mice immunized with hTg, in the 
absence  of  PHCCC  treatment,  whereas  significant  decreases  in  the 
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concentrations  of  this  cytokines  were  detected  in  the  supernatants  of 
splenocytes from both control mice immunized with PBS and mice immunized 
with  hTg  with  added  PHCCC  treatment.  Thus,  the  selective  inhibition  of 
differentiation of hTg-specific TH17 effector cells by PHCCC was sufficient to 
cause the effective suppression of EAT, even though the differentiation and 
phenotypiic expression of TH1 effector cells did not seem to be affected. This 
result outlines the determinant role of the participation of effector TH17 cells to 
the autoimmune response towards the thyroid gland, for the establishment of 
thyroid organ disease. These results represent also an indirect confirmation of 
the causative  role  of  the  selective  enhancement  of  Th17 differentiation  and 
phenotypic  expression  determined  by the  CS  unit  of  hTg  in  the  improved 
induction of EAT by hTgCS, as observed in the assays of cytokine production 
by CD4+ T cells isolated from the spleens of CBA/J(H-2k) mice immunized and 
restimulated with hTgCS, in comparison with hTgCS0 (Figures 22).
Fig  22. Assays  of  cytokine  secretion  in  the  supernatants  of  secondary  proliferative 
responses by splenocytes of  CBA/J mice immunized with hTg, without or with added 
PHCCC treatment. The levels of IL-2, IL-6, IL-17, INF-γ were mesured in the supernatants 
of secondary proliferative responses of splenocytes from CBA mice immunized with hTg plus 
the sole vehicle (sesame oil) of PHCCC administration, or hTg plus added PHCCC treatment,  
after restimulation with hTg at  the dose of  150  μg/mL. Anti-CD3 antibodies were used as 
positive controls. Results are expressed as means ± S.D.
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4.10 CD44 is the receptor of the CS oligosaccharide unit of hTg at the 
surface of murine CD4+ T cells
As  previusly  indicate  in  the  introduction,  CD44  was  showed  to  be 
implicated in the development of adaptive and innate immune responses. In 
addiction many evidences showed both that CS can bind CD44, and that this 
interaction  can  influence  the  CD44  functions  on  the  adaptive  and  innate 
immune responses.  To evaluate if CS unit of hTg effectivily, was bounded to 
CD44 at  the  surface  of  lymphocyte  T CD4+ we  performed  an  SDS PAGE 
experiment.  Lymphocytes  T CD4+  from mice  immunized  with  hTgCS were 
stimulated  in  vitro with  anti-CD28  plus  anti-CD3  and  incubated  with 
biotinilated  hTgCSgp  glycopeptide  linked  to  bifunctional  p-Azidobenzoyl 
hydrazid photo-activable cross linker.  After  irradiation at  365 nm and wash 
procedure,  biotinilated  hTgCSgp  glycopeptide  linked  to  bifunctional  p-
Azidobenzoyl hydrazid photoactivable cross linker, resulted covalently linked 
to  the  receptor  recognized  at  the  surface   of  lymphocyte  T CD4+.  Finally, 
cellular  lysis  procedure,  samples  were  immunoprecipitated  with  anti  biotin 
antibody  and  immunobloted  with  anti-biotin  and  anti-CD44.  As  shown  in 
figure  23.  The immunoblot  showed that  biotinilated  hTgCSgp glycopeptide 
linked  to  bifunctional  p-Azidobenzoyl  hydrazid  photoactivable  cross  linker, 
was bounded to CD44 at the surface of lymphocyte T CD4+.
This  result  was  confirmed  by  confocal  microscopy  experiment 
effetuated on the same cells which were used for the immunoblot analisis. As 
showed  in  figure  24,  the  colocalization  between  hTgCSgp  glycopeptide 
biotinilated and linked with bifunctional and photo-activable p-Azidobenzoyl 
hydrazid cross linker with CD44 recertor was an other prove af this interaction.
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Fig 23. Immunoblots of lysates of CD4+  T cells isolated from the spleens of CBA/J(H-2k) 
mice,  incubated  with  the  biotinylated  hTgCSgp  glycopeptide  covalently  linked to  the 
bifunctional  cross-linker  p-azidobenzoyl  hydrazide and immunoprecipitated  with  anti-
biotin or anti-CD44 antibodie. Lanes 1-3: unstimulated CD4+ T cells. Lanes 2-4: CD4+ T cells 
stimulated  with  aCD3/aCD8 antibodies.  All  samples  were  incubated  with  the  biotinylated 
hTgCSgp glycopeptide covalently linked to the photoactivatable, bifunctional cross-linker  p-
azidobenzoyl hydrazide.
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Fig 24. Confocal microscopy of CD4+ cells isolated from the spleens of CBA/J(H-2k) mice 
and  incubated  with  the  biotinylated  hTgCSgp  glycopeptide  covalently  linked  to  the 
photoactivatable, bifunctional cross-linker p-azidobenzoyl hydrazide. A, D, G,  CD4+ cells 
exposed to anti-biotin-PE; B, E, H,  CD4+ cells exposed to anti-CD44-FITC; C, F, I, image 
merge.
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5 DISCUSSION
The  data  presented  in  this  work  document  that  the  presence  of  a 
chondroitin 6-sulphate (CS) oligosaccharide unit linked to Ser2730 of human 
thyroglobulin (hTg) (Conte et al., 2006) was associated with a marked increase 
of  the  immunopathogenicity  of  hTg  in  a  model  of  murine  experimental 
autoimmune thyroiditis (EAT) in CBA/J(H-2k) and SJL(H-2s) mice. When used 
to immunize CBA/J mice, CS-containing hTg (hTgCS) markedly enhanced, in 
comparison  with  CS-devoid  hTgCS0,  the  infiltration  of  murine  thyroids  by 
mononuclear cells, the leak of thyroid hormones from thyroid epithelial cells 
into the bloodstream and the secondary proliferative and secretory responses of 
splenocytes  and isolated CD4+ T cells  to both hTgCS and hTgCS0 in vitro. 
These results indicated that the CS oligosaccharide unit of hTg is capable of 
enhancing  markedly the  primary  sensitization  of  murine  T cells  to  peptide 
epitopes shared between hTgCS and hTgCS0 and conserved between human 
and  murine  Tg.  Moreover,  the  cytokine  secretion  patterns  obtained  with 
isolated  murine  CD4+ T cells  indicated  that  the  CS unit,  both  as  a  part  of 
hTgCS and in the form of a purified, CS-containing nonapeptide isolated to 
homogeneity  from  hTgCS  (hTgCSgp),  was  capable  of  enhancing  the 
differentiation of Tg-reactive  TH1 and  TH17  cells. Furthermore, the response 
patterns of murine CD4+ T cells to hTgCS and hTgCSgp, also in relation with 
the responses to anti-CD3 and anti-CD28 antibodies, indicated that the CS unit 
of hTg did not behave as a pathogenic epitope in itself, but rather as an added 
co-stimulus for the differentiation of Tg-specific  TH1 and  TH17 cells, thereby 
promoting strongly thyroid disease. Finally, two-step cross-linking experiments 
and  confocal  microscopy  of  murine  CD4+ T  cells  exposed  to  the  purified 
hTgCS  glycopeptide  indicated  that  the  CS  oligosaccharide  unit  of  hTg 
interacted specifically with CD44 of murine CD4+ T cells.
The above observations invite a number of comments:
1.
EAT has been known so far for being characterized by low-grade, focal 
mononuclear  infiltration  of  thyroid  glands,  even  in  genetically  susceptible 
murine strains. Investigators working in the field were used to observe even 
lower-grade  mononuclear  cell  infiltration  into  the  thyroids  of  experimental 
animals, when human Tg (hTg) was used as the immunizing agent, instead of 
murine Tg (mTg), even though it is generally accepted that EAT results from 
the recognition by murine autoreactive T cells of epitopes which are conserved 
between  mTg  and  hTg.  We  have  shown  previously  that  hTg  is  regularly 
composed of a mixture of hTgCS0 and hTgCS, in broadly variable proportions 
among different individuals (Conte  et al., 2006). In the light of the data here 
reported,  it  appears  that  the  induction  of  autoimmune  thyroid  disease  in 
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experimental animals depends prevailingly or solely on the hTgCS fraction of 
hTg. Because investigators in the field have been using so far unfractionated 
hTg for the purpose of inducing EAT, it appears that the variable severity of 
EAT observed in many studies was deeply influenced by the composition of the 
particular hTg preparations used, not only with regard to the percent abundance 
of hTgCS, but possibly also to the average chain length of the chondroitin 6-
sulfate  chain  linked  to  each  hTg  subunit  and  to  the  relative  proportion  of 
heterodimeric and homodimeric hTgCS.
2.
The data presented here highlight the essential contribution of the TH17 
polarization of the differentiation of effector T helper cells in the pathogenesis 
of EAT. They also indicate the inhibition o the differentiation of TH17  cells as 
the most probable mechanism of action of the immunomodulator drug PHCCC, 
as  suggested  by  other  observations  collected  in  the  murine  models  of 
experimental autoimmune encephalomyelitis (EAE) (Fallarino et al., 2010) and 
experimental autoimmune neuritis (EAN) (Zappulla et al., 2011).
The  primary  role  of  IL-17  and  IL-17-secreting  T cells  was  already 
appearing from the experimentl strategy employed for the induction of murine 
experimental  granulomatous thyrodiditis  (G-EAT),  by the use of  anti-IL-2R 
antibodies or IFN-γ, in addition to T cells sensitized in vivo  and re-exposed in  
vitro to Tg (Braley-Müllen  et al., 1991). In fact, IFN-γ secreted by TH1 cells 
inhibits the IL-23-dependent expansion of TH17 cells, while IL-2 abolishes IL-
17  production  and  induces  IFN-γ  production  by  the  same  cells.  It  was 
hypothesized that TH17 cells may participate in the autoimmune granulomatous 
reaction by supporting, on one hand, the inflammatory response, via the release 
of pro-inflammatory cytokines (TNF-α, IL-6 and IL-17) and, on the other hand, 
by recruiting  neutrophile  granulocytes  and  macrophages,  via  the  release  of 
chemokines and growth factors (CCL2/MCP-1, CCL3/MIP-1, G-CSF) (Chen 
et al., 2005). TH17 are known as a source of pro-inflammatory cytokines IL-17 
(IL-17A), IL-17F, IL-22, IL-6 e TNF-α, as well as GM-CSF. By binding to IL-
17R (IL-17RA) receptors on fibroblasto, macrohages, astrocytes, epithelial and 
endothelial  cells,  IL-17  orchestrates  tissue  inflammation,  inducing  the 
expression of cytokines, such as IL-6 and TNF-α, chemokines, such as CCL2 
(MCP-1,  macrophage chemotactic protein 1) and CCL3 (MIP-1), and matrix 
metalloproteases, which mediate the infiltration and tissue destruction. IL-17 
also induces the production of G-CSF, which promotes the development and 
the  differentiation  of  neutrophile  granulocytes  and  cooperates  in  T  cell 
activation and DC maturation. The data reported in the present study document 
distinct associations between the increases in the production of IL-17 and IL-6 
and the more efficient induction of EAT by hTgCS, both as an immunizing 
agent in primary sensitization in vivo and a restimulating antigen in secondary 
proliferative responses  in vitro. A substantial contribution of the amelioration 
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of the responses of Tg-specific  TH1 cells (both at the stage of differentiation 
and of activation of their phenotypic expression) by the use of chondroitinated 
form of hTg (hTgCS) to the development of EAT also emerged from the study 
of the patterns of cytokine secretion associated with the proliferative responses 
in vitro of T cells from the various experimental mice groups. Taken together, 
the data  presented  here  indicate  that  an interplay between the  responses  of 
antigen-specific  effector  TH1 and  TH17 cells  seems to  be  necessary for  the 
development  of  autoimmune  thyroid  disease,  far  beyond  the  experimental 
model of G-EAT, to include classical forms of chronic lymphocytic thyroiditis, 
such  as  EAT,  and  that  the  balance  between  these  two  components  of  the 
effector  response  might  determine  the  severity  and  the  progression  rate  of 
organ disease, by modulating the extent and intensity of those aspects of the 
immune response wich are more connected with the inflammatory reaction, 
such as the homing of antigen-specific armed effector T cells in target tissues 
and  organs.  The  data  presented  permit  a  finer  dissection  between  different 
modalities by which the CS unit  exerts  its enhancement of  TH1- and  TH17-
mediated responses. The cooperation to the differentiation of antigen-specific 
naïve  T  cells  into  effector  TH1  cells  seemed  to  occur  in  the  form  of  an 
accessory costimulation, mediated by and synergistic with CD28 costimulation. 
However,  simultaneous  CD28-mediated  costimulation  did  not  appear  to  be 
conditional for the (re)activation of effector memory TH1 cells by the CS unit. 
This may not surprise, as a relative independence from classical costimulation 
is a hallmark of effector memory T cells. However, it is of importance to notice 
that, in our experimental setting, the sensitivity to CS-dependent costimulation 
appeared to be expressed in a privileged and almost exclusive manner by T 
cells which had been sensitized in vivo in the presence of the CS unit (i.e., in 
mice  immunized  with  hTgCS)  and  seemed  to  provide  a  pathway  for  the 
reactivation  of  these  cells,  which  was  largely  TCR-independent.  Such  a 
peculiar  feature  of  the  differentiation  of  effector  TH1  cells  induced  or 
modulated by the CS unit may provide a potent mechanistic rationale for the 
maintenance of the autoimmune reaction towards the thyroid, well beyond the 
episodical settings and circumstances in which the breaking of the tolerance to 
self antigens had become possible. On the other hand, the contribution of the 
CS unit  to  the differentiation of  antigen-specific  naïve T cells  into  effector 
TH17 cells, even though also synergistic with CD28-mediated costimulation, 
seemed to be also conditional for the latter, which was deprived of effect in the 
absence of simultaneous stimulation by CS. That is  to say that the CS unit 
provided  a  unique,  qualitative  contribution  to  the  enforcement  of  a  TH17 
component in the induction of EAT in hTgCS-immunized mice. As in the case 
of TH1 cells, simultaneous CD28-mediated costimulation did not appear to be 
required, instead, for the (re)activation of effector  TH17 cells by the CS unit 
either. As with TH1 cells, the sensitivity of effector TH17 cells to CS-dependent 
(re)activation  also  was  expressed  almost  exclusively  by T cells  from mice 
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immunized with hTgCS. However, at variance with TH1 cells, the activation of 
these cells was strictly dependent also upon the stimulation of TCR. Such a 
phenotypic feature of the  TH17 cells differentiated in response to the  in vivo 
sensitization  to  hTgCS  may  provide  a  mechanistic  explanation  for  the 
pathogenetic role commonly attributed to TH17 cells in cytotoxc cell-mediated 
hypersensitivity and autoimmune reactions, that is, to set up local conditions 
within  the  context   of  target  tissues  and organs,  i.e.,  in  coincidence  of  the 
source  of  target  antigens,  for  the  extravasation,  invasion,  cell  and  tissue 
damaging actions of TH1, CD8+ cytotoxic cells and activated macrophages.
In  this  perspective,  the  data  reported  in  the  present  study,  besides 
confirming  the  immunomodulatory  properties  of  PHCCC  and  its  potential 
utility  in  the  control  of  autoimmune  diseases,  also  shed  light  onto  general 
pathogenetic mechanisms of autoimmunity, both within and outside the thyroid 
field, with special regard to the respective functions of TH1 and TH17 cells and 
their cooperation. The role of TH1 cells in autimmunity has been known for a 
long time. In murine models of autoimmune diseases, such as type 1 diabetes 
and EAE, CD4+, IFN-γ-producing T cells were capable of inducing the disease 
in  syngeneic  hosts  by  adoptive  transfer.  Moreover,  TH1-type  cytokines  are 
found  in  inflammatory  lesions  of  the  CNS  in  correspondence  with  acute 
disease  phases  and  their  disappearance  is  related  with  clinical  healing. 
Experimental animals with defects of transcription factors STAT-4 and T-bet do 
not  produce IFN-γ and are resistant  to the induction of EAT. However,  the 
observation that IFN-γ-defective experimental mice lacking IFN-γ, IFN-γR or 
transcription  factor  STAT-1  are  even  more  prone  to  develop  autoimmunity 
suggested  the  existence  of  a  distinct,  pathogenetically  important  T  cell 
population, subsequently identified as  TH17 cells (Bettelli  et al.,  2007). The 
deficit  of  IL-17  or  its  treatment  with  antagonists  of  IL-17R  prevent  the 
development  of  murine  adjuvant-induced  arthritis,  whilst  IL-17-blocking 
antibodies prevent the development of EAE. The latter has a slower and milder 
course  in  IL-17-defective  mice.  Also  IFN-γ  protects  mice  from  EAE. 
Moreover, murine defects of IL-27R are associated with severe autoimmune 
pathologies and increases in  the production and homing to target tissues of 
TH17 cells, while, in the presence of STAT-1 defects, exhacerbations of EAE 
are observed, with increased recruitment of macrophages and neutrophils into 
the CNS. These observations support a critical pathogenetic role of TH17 cells 
in  autoimmune  diseases,  considering  that  IL-23 promotes  the  expansion  of 
differentiated  TH17  cells,  while  IL-27  and  IFN-  suppress,  respectively,  the 
differentiation of TH17 cells and their IL-23-driven expansion, both in a STAT-
1-dependent manner. It appears that both TH1 e TH17 cells are involved in the 
induction of autoimmunity, which is further supported by the observation that 
mice lacking  TH1 cells (due to defects of STAT-4 and Tbet)  are resistant to 
EAE,  even though they have  an  excess  of  TH17 cells.  In  fact,  T cells  and 
cytokines of both types are found in murine CNS during the EAE climax and 
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develop  from  transgenic  T  cells,  with  myelin-reactive  TCRs,  capable  of 
inducing  EAE  by  adoptive  transfer.  The  data  presented  here  are  fully 
concordant with this scenario and add further insight into the vision, according 
to  which  it  is  probable  that  effector  TH17 cells  are  produced earlier  in  the 
autoimmune  process  and  direct  the  early  phase  of  acute,  immune-driven 
inflammation,  whereas  TH1  cells  prolong  and  perpetuate  the  autoimmune 
adaptive response (Bettelli et al., 2007).
3.
The data discussed so far, concerning the critical importance of the CS 
unit of hTg in the development of EAT and the role of  TH17 cells and their 
interplay with  TH1 cells  in mediating the actions of the CS unit  are further 
supported and strengthened by our identification of CD44 as the receptor of the 
hTgCSgp glycopeptide on murine CD4+ T cells. The importance of CD44 and 
the multiplicity of its roles within the context of innate and adaptive immune 
responses was extensively accounted for in the introductory part of this thesis. 
CD44  was  repeatedly  shown  to  act  as  a  costimulatory  molecule  and  an 
antiapoptotic effector. Our results indicate that CS exerts strong actions on the 
development  of  EAT by  the  means  of  a  costimulatory  influence  upon  the 
primary  sensitization  of  Tg-specific  CD4+ T  cells.  Such  costimulation  was 
synergistic  with  CD28-mediated  csotiumulation.  However,  while  it  was 
accessory in nature with regard to the differentiation of TH1 cells, it appeared to 
be conditional and indispensabile for TH17 differentiation. In both cases, the 
effects  of  CS  appeared  to  be  mediated  by  CD44.  Our  observations  are 
consistent  with  recent  work  by  several  investigators,  although  in  different 
contexts  of  autoimmune disease.  Guan and coworkers  showed that  targeted 
deletion  of  CD44  attenuated  myelin  oligodendrocyte  glycoprotein  (MOG) 
peptide-induced EAE, through novel regulatory mechanisms affecting TH cell 
differentiation. CD44 deficiency on CD4+ T cells  conferred protection against 
EAE  induction.  CD44  was  shown  to  play  a  crucial  role  in  TH cell 
differentiation,  inasmuch as  deletion  of  the  CD44 gene  inhibited  TH1/TH17 
differentiation,  while  simultaneously enhancing TH2/TREG cell  differentiation 
(Guan  et  al.,  2011).  The  expression  of  CD44  promoted  TH1/TH17 
differentiation. In fact, when osteopontin and hyaluronic acid, the two major 
CD44 ligands, were tested for their role in TH cell differentiation, osteopontin 
(Opn),  but  not  hyaluronic  acid,  promoted  TH1/TH17  differentiation. 
Furthermore, activation of CD44+ encephalitogenic T cells with MOG peptide 
led to demethylation at the ifn-γ/il17a gene promoter region, while promoting 
hypermethylation  at  the  il4/foxp3 gene  promoter.  Therefore,  in 
encephalitogenic T cells, CD44 plays a crucial role in the differentiation of TH 
cells,  through epigenetic  regulation,  namely,  DNA methylation of TH1/TH17 
and TH2 cytokine genes (Guan  et al., 2011). Moreover, Opn inhibited IL-10 
production via the CD44 receptor CD44R and anti-Opn treatment reduced the 
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clinical  severity  of  EAE by reducing  IL-17 production  (Murugaiyan  et  al., 
2008).
As for the role of CD44 as a costimulatory molecule, a number of non-
CD28 costimulatory molecole, such as CD5, CD9 and CD2, including CD44, 
were shown to be present in the detergent-insoluble glycolipid-enriched (DIG) 
fraction/raft of the T cell surface, which is rich in TCR signaling molecules and 
generates a TCR signal upon recruitment of the TCR complex (Ohtani  et al., 
2000). Moreover, certain anti-CD44 mAbs can activate human resting T cells 
and mouse cytotoxic T cells in the absence of anti-CD3 or anti-CD2 mAb. An 
anti-CD44 mAb triggered proliferation of human CD3+/CD4+ T cell clones in a 
similar  fashion  as  observed  with  mAbs  to  CD3  (Galandrini  et  al.,  1993). 
Finally, with regard to the anti-apoptotic role of CD44, it was shown that the 
CD44v6 and CD44v9 isoforms exhibit anti-apoptotic effects and could block 
Fas-mediated  apoptosis.  Importantly,  an  anti-CD44v6  antibody was  able  to 
abolish the anti-apoptotic effect of CD44v6 (Mielgo et al., 2006).
4.
The wide range of variation of the percentage abundance of hTgCS in 
whole hTg which can be observed in humans (Conte  et  al.,  2006)  and the 
documented effects  of the CS oligosaccharide unit  upon hTg hormonogenic 
efficiency (Conte et al., 2006) and the hTg immunopathogenic capacity in the 
murine model of EAT documented here warrant a systematic investigation of 
the possible relationships between the percentage amount of hTgCS in thyroid 
colloid substance and thyroid function and pathology. The measure of hTgCS 
fraction of hTg may turn out to be a useful marker of prognostic usefulness in 
the assessment of the risk of autoimmune thyroid disease (AITD) in humans, 
under conditions which are known to favour it,  such as borderline,  chronic 
iodine  deficiency,  smoking,  acute  or  subacute  thyroiditis  and  genetic 
polymorphisms of the Tg, CTLR4, HLADRB1 and PTPN22 genes).
5.
The actions documented here by the CS unit of hTg and its receptor 
CD44 on the development of autoimmune thyroid disease may pave the way to 
further  experimentation,  aiming  at  evaluating  the  feasibility  and  possible 
usefulness, in animal models of autoimmune thyroid disease and possibly in 
the setting of human disease, to targeted strategies of metabolic and/or genetic 
interference with the chondroitin sulfate addition to thyroglobulin (by the use 
of metabolic inhibitors or genetic silencing of xylosyl transferases), or of CD44 
expression in the cells of the immune system (by the use of specific miRNAs), 
for  the  prevention  of  autoimmune  thyroid  disease,  in  the  presence  of  risk 
factors, or the immunomodulation of established disease.
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A great variety of compounds are formed during lipid peroxidation of polyunsaturated
fatty acids of membrane phospholipids. Among them, bioactive aldehydes, such as
4-hydroxyalkenals, malondialdehyde (MDA) and acrolein, have received particular attention
since they have been considered as toxic messengers that can propagate and amplify
oxidative injury. In the 4-hydroxyalkenal class, 4-hydroxy-2-nonenal (HNE) is the most
intensively studied aldehyde, in relation not only to its toxic function, but also to its
physiological role. Indeed, HNE can be found at low concentrations in human tissues
and plasma and participates in the control of biological processes, such as signal
transduction, cell proliferation, and differentiation. Moreover, at low doses, HNE exerts
an anti-cancer effect, by inhibiting cell proliferation, angiogenesis, cell adhesion and by
inducing differentiation and/or apoptosis in various tumor cell lines. It is very likely that
a substantial fraction of the effects observed in cellular responses, induced by HNE and
related aldehydes, be mediated by their interaction with proteins, resulting in the formation
of covalent adducts or in the modulation of their expression and/or activity. In this review
we focus on membrane proteins affected by lipid peroxidation-derived aldehydes, under
physiological and pathological conditions.
Keywords: lipid peroxidation, aldehydes, membrane proteins, human diseases, signal transduction
INTRODUCTION: LIPID PEROXIDATION-DERIVED
ALDEHYDES
Reactive intermediates produced under conditions of oxidative
stress cause the oxidation of polyunsaturated fatty acids (PUFAs)
in membrane lipid bilayers, leading eventually to the formation
of aldehydes (Esterbauer et al., 1991). Among these, the most
abundant aldehydes are 4-hydroxy-2-nonenal (HNE) and mal-
ondialdehyde (MDA), while acrolein is the most reactive one
(Esterbauer et al., 1991). HNE is the lipoperoxidation prod-
uct which has displayed the highest biological activity and, for
this reason, has been most intensively studied. On the other
hand, acrolein, which is the most electrophylic compound, has
received less attention, because it is scarcely represented among
lipoperoxidation products. Both acrolein and HNE are α,β-
unsaturated electrophilic compounds, which preferentially form
1,4-Michael type adducts with nucleophiles, such as proteins
and DNA. Even though MDA shows little reactivity under phys-
iological conditions, at low pH its reactivity increases, when
beta-hydroxyacrolein becomes the predominant species and,
analogously to acrolein and HNE, it can form 1,4-Michael type
adducts with nucleophiles (Esterbauer et al., 1991). Even though
it was demonstrated that MDA does not react with glycine and
GSH, and reacts slowly with cysteine (Esterbauer et al., 1991)
under physiological conditions, cellular proteins are much more
readily modified by MDA (Chio and Tappel, 1969).
Due to the high chemical reactivity of aldehydes, mammals
have evolved a battery of enzymes which convert these com-
pounds to less reactive chemical species. The main reactions
of aldehydes are the adduction with glutathione (GSH), which
can either occur spontaneously or be catalyzed by glutathione
S-transferases (GSTs), the reduction to alcohol by aldo–keto
reductases (AKRs) or alcohol dehydrogenase and the oxidation to
acid by aldehyde dehydrogenases. The metabolism of aldehydes
has been reviewed in excellent mode by Esterbauer and collab-
orators (1991). More recent reviews were focused on the bio-
chemistry of lipid peroxidation products (Guéraud et al., 2010)
and acrolein biotransformation (Stevens and Maier, 2008). The
catabolic rates of the various aldehydes contribute, together with
their rates of production from lipid peroxidation, in determining
their steady-state intracellular concentrations. At high concentra-
tions, all these aldehydes were found to play a role in the toxic
effects of lipid peroxidation. Aldehyde toxicity is mainly due to the
alterations of several cell functions, which mostly depend on the
formation of covalent adducts with cellular proteins (Grimsrud
et al., 2008). Due to their amphiphilic nature, aldehydes can easily
diffuse across membranes and can covalently modify any protein
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in the cytoplasm and nucleus, far from their site of origin (Negre-
Salvayre et al., 2008). Similarly, the aldehydes formed outside the
cells (i.e., in a site of inflammation or in plasma), can react with
adjacent cells, even in cases when they are not primary sites of
lipid peroxidation. In the latter instance, plasma membrane pro-
teins represent the first targets for adduct formation. Exogenous
or endogenous aldehydes can react also with nuclear proteins,
thus modulating protein expression through their reaction with
transcription factors or other regulatory elements (Jacobs and
Marnett, 2010). The targets of lipid peroxidation-derived alde-
hydes are cell-type specific and dependent both on the pattern
of proteins expressed by the cell and the aldehyde concentration.
Moreover, the modification of a specific protein can have different
biological consequences, in relation to its specific cell function.
However, at low concentration, HNE in particular can play an
important role in signal transduction and exert antiproliferative
and anti-invasive actions toward cancer cells, by interfering with
the modulation of gene expression via the formation of protein
and/or DNA adducts (Gentile et al., 2009; Barrera, 2012).
The presence of aldehyde-protein adducts has been demon-
strated in a wide range of physiological and pathological con-
ditions. Those among the latter in which aldehyde-protein
adducts, in particular HNE-protein adducts, have been most
intensively studied are neurodegenerative diseases and atheroscle-
rosis. Recently, a role has emerged for aldehyde-protein adducts
in autoimmune diseases, since the covalent alteration of protein
structure can bring about a sufficient modification of a self anti-
gen for it to break the immunological tolerance of autoreactive
T and/or B cells. In the following sections, we shall examine
the mechanisms of formation of aldehyde-protein adducts and
the main biological consequences of the formation of aldehyde
adducts with membrane proteins in neurodegenerative diseases,
atherosclerosis, autoimmune diseases and in relation with the
functions played by cell proteins at the plasma membrane level.
The chemical structures of HNE, MDA and acrolein are illus-
trated in Figure 1
CHARACTERISTICS OF ALDEHYDES AND THEIR PROTEIN
ADDUCTS
4-HYDROXYNONENAL (HNE)
4-Hydroxynonenal (HNE) is an aldehyde highly represented
among the products of lipid peroxidation, which displays high
biological activity. This aldehyde has three main functional
groups: the aldehyde group, the C=C double bond and the
FIGURE 1 | Structures of 4-hydroxy-2-nonenal (HNE), malondialdehyde
(MDA) and acrolein.
hydroxyl group, which can participate, alone or in sequence, in
chemical reactions with other molecules (Esterbauer et al., 1991).
Due to its strong hydrophobic nature, HNE is mostly associated
with the membranes where it is produced, but it can also diffuse
to different cellular compartments (Butterfield and Stadtman,
1997). HNE is a highly electrophilic molecule that easily reacts
with glutathione, proteins and, at higher concentration, with
DNA. HNE forms adducts with three different amino acyl side
chains, namely of Cys, His, and Lys residues, via Michael addi-
tion either to thiol (−SH) or to amino (−NH2) groups. Cys
residues display the highest reactivity with HNE, even though Cys
residues are not always the preferential targets of HNE, because
the tertiary structure of the protein can condition their accessi-
bility and, therefore, their reactivity toward exogenous chemicals.
No reaction of HNE was detected with Glu (Doorn and Petersen,
2003). Besides by the simple formation of Michael adducts to
lysyl, histidyl, and cysteinyl residues (Esterbauer et al., 1991),
HNE can modify protein structure through Schiff base forma-
tion with lysyl residues, leading to pyrrole formation (Sayre et al.,
1996). In addition, HNE modification can result in the cross-
linking of two lysyl residues through reversibly formed Schiff base
Michael adducts (Parola et al., 1999; Xu et al., 1999), as well as
irreversibly formed 2-hydroxy-2-pentyl-1,2-dihydropyrrol-3-one
iminium moieties (Parola et al., 1999; Dianzani, 2003; Barrera
et al., 2008). The target proteins of HNE adduct formation in vitro
and in vivo have been reviewed in great detail by Poli et al. (2008).
HNE has been detected in vivo in several pathological con-
ditions characterized by increased lipid peroxidation, including
inflammation, atherosclerosis, chronic degenerative diseases of
the nervous system, and chronic liver diseases (Moreau et al.,
2005).
ACROLEIN
Acrolein is a little aldehyde with three carbon atoms and a double
bond. Besides being formed endogenously during lipid perox-
idation, this aldehyde is inhaled with cigarette smoke and is
present in cooked oils and other foods (Stevens andMaier, 2008).
Acrolein is the strongest electrophile in the α,β-unsaturated alde-
hyde series; its reaction with the thiol group of cysteine was about
110–150 times faster than that of HNE (Esterbauer et al., 1991;
Witz, 1997). The toxicity of acrolein is related to its ability to
deplete glutathione (Kehrer and Biswal, 2000), and to form DNA
and protein adducts (Esterbauer et al., 1991; Sanchez et al., 2005;
Feng et al., 2006). Potential targets of acrolein in proteins include
the side chains of cysteinyl, histidyl, and lysyl residues, as well as
free N-terminal amino groups (Cai et al., 2009). Cysteine is widely
accepted as the most likely site of acrolein adduct formation.
The sulfhydryl group of a cysteinyl residue is the most reac-
tive nucleophile in proteins and the thiol adducts with acrolein
are considerably more stable than the adducts formed by other
α,β-unsaturated aldehydes (Esterbauer et al., 1991; Witz, 1997).
Cysteinyl residues are located at the active sites of several proteins
and are often involved in the catalytic activity of enzymes, thus
the formation of acrolein-cysteine adducts has broad functional
implications. It has been reported that the modification of cys-
teinyl residues by acrolein leads to the inactivation of enzymes,
such as aldose reductase (Srivastava et al., 1999) and protein
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tyrosine phosphatase 1B (Seiner et al., 2007). However, no cys-
teine adducts of acrolein have been identified in vivo. Other
Authors have shown that acrolein generated during lipid perox-
idation may primarily react with histidyl residues of proteins, to
form Nτ-(3-propanal)-histidine and that acrolein-histidine is the
major adduct formed with proteins in in vitro studies (Maeshima
et al., 2012).
Elevated plasma concentrations of acrolein are detected in
patients with chronic renal failure, and the abundance of the pro-
teins adducts of acrolein is increased in tissues obtained from
patients with Alzheimer’s disease, Parkinson’s disease, atheroscle-
rosis and chronic obstructive lung disease (Uchida et al., 1998a;
Shamoto-Nagai et al., 2007; Stevens and Maier, 2008; Moretto
et al., 2012).
MALONDIALDEHYDE (MDA)
Malondialdehyde (MDA) is widely used as a marker for the per-
oxidation of ω3 and ω6 fatty acids, measured by the chemical
determination of thiobarbituric acid reactive substances (TBARS)
(Negre-Salvayre et al., 2010), although the latter provides an
incomplete perspective, as MDA derives from the decompo-
sition of only certain lipid peroxidation products and is nei-
ther the sole end product, nor one of lipid peroxidation only
(Halliwell and Whiteman, 2004). At neutral pH, MDA is present
as enolate anion, with low chemical reactivity (Esterbauer et al.,
1991). Nevertheless, it is able to interact with nucleic acid
bases to form several different adducts (Marnett, 1999). MDA
has been reported to react in vivo with primary amines, to
form Nε-(2-propenal) lysine and generate lysine-lysine cross-
links with 1-amino-3-iminopropene and pyridyledihydropyri-
dine type bridges (Uchida, 2000). These reaction products have
been detected in Apo B fractions of oxidized lipoproteins (LDL)
and are thought to be involved in the impaired interaction of
modified lipoproteins with macrophages (Palinski et al., 1994).
Mooradian and coworkers have reported that protein glycosyla-
tion and the presence of acetaldehyde enhanceMDAmodification
of proteins (Mooradian et al., 1996, 2001). Moreover, MDA and
acetaldehyde can form stable adducts (MAA) (Tuma et al., 1996)
and can react covalently and synergistically with proteins, form-
ing MAA–protein adducts. The latter can be pro-inflammatory
and pro-fibrogenic and are capable of inducing strong immune
responses (Tuma, 2002).
PHOSPHATIDYL γ-HYDROXYALKENALS (PC-HAs)
Phosphatidylcholine γ-hydroxyalkenals (PC-HAs) are the most
abundant and biologically relevant compounds in the class of
γ-hydroxyalkenal phospholipids, deriving from the peroxidation
of polyunsaturated fatty acids (PUFAs) esterified to phospho-
glycerides at the sn-2 position of phosphatidylcholine (PC).
β-Scission of an alkoxyl radical derived from dihydroperox-
ide produces two γ-hydroxy-α,β-unsaturated aldehydes, i.e., a
methyl-terminal HNE molecule and a mirror image of HNE,
still esterified to PC (namely, 9-hydroxy-12-oxo-10-dodecenoic
acid [HODA] or its PC ester from linoleate and 5-hydroxy-8-
oxo-6-octenoic acid [HOOA] or its PC ester from arachidonate).
Because they possess a γ-hydroxy-α,β-unsaturated terminal alde-
hyde like HNE, PC-hydroxyalkenals are expected to formMichael
adducts with primary amino groups of lysyl residues and thiol
groups of cysteinyl residues, as well as pentylpyrrole adducts,
incorporating the ε-amino groups of lysyl residues (Figure 2). γ-
Hydroxyalkenal phospholipids contribute strongly in the patho-
genesis of the atherosclerotic disease. ω-Carboxyalkylpyrrole
modifications of proteins, after lypolysis of intermediate phos-
pholipid adducts, are of pathogenetic importance in age-related
macular degeneration, autism and cancer, and promote wound
healing. In regard, the reader is referred to the excellent reviews
by Salomon et al. (2011), and Salomon and Gu (2011).
ALDEHYDE-PROTEIN ADDUCTS IN NEURODEGENERATIVE
DISEASES
Central nervous system (CNS) is one of the major targets of
lipid peroxidation. The brain is highly sensitive to oxidative
stress because it consumes about 20–30% of inspired oxygen and
contains high levels of PUFAs. In particular, high levels of the
markers of lipid peroxidation have been found in brain tissues
and body fluids in several neurodegenerative diseases, including
Alzheimer’s disease (AD), Parkinson disease (PD), amyotrophic
lateral sclerosis (ALS), Huntington disease (HD) and Down syn-
drome (DS) (Sajdel-Sulkowska and Marotta, 1984; Butterfield
et al., 2010; Ruiperez et al., 2010; Lee et al., 2011; Shichiri et al.,
2011). We focus here on the adducts of lipid peroxidation-derived
aldehydes with protein targets whose oxidative modifications
might be relevant for the neuronal dysfunctions observed in
Alzheimer’s disease.
ALZHEIMER’S DISEASE (AD)
Oxidative damage occurs in early stages of Alzheimer’s dis-
ease (AD) (Butterfield et al., 2006a; Reed et al., 2008, 2009a;
Mangialasche et al., 2009). Several Authors, using redox pro-
teomic approaches, have undertook the task of compiling inven-
tories of cellular proteins modified as a consequence of increased
oxidation, glycoxidation, or lipoxidation in the course of oxidative
and/or nitrosative stress (Pamplona et al., 2005; Butterfield et al.,
2006b; Newman et al., 2007; Reed et al., 2008, 2009a,b; Perluigi
et al., 2009). Other searches focused upon proteins modified by
tyrosine nitration (Castegna et al., 2003; Sultana et al., 2006a;
Reed et al., 2008) and S-glutathionylation (Newman et al., 2007).
A number of comprehensive reviews are available (Mangialasche
et al., 2009; Martínez et al., 2010; Reed, 2011; Sultana et al.,
2012). Like in other neurodegenerative diseases with proteina-
ceous deposits, vulnerable proteins could be assigned to a few
distinct functional groups with crucial roles in plasmamembrane
ion and nutrient transport, energy metabolism (glycolysis, mito-
chondrial electron transport and oxidative phosphorylation), cell
signaling, cytoskeletal organization, antioxidant defenses, cellu-
lar stress responses, protein synthesis, signal transduction, and
regulation of neurotransmission (Table 1).
HNE-Amyloid β peptide adducts
Amyloid β (Aβ) peptide is the major protein component of amy-
loid plaques and one of the main components of neurofibrillary
tangles (NFTs), hallmarks of AD. This molecule is a 40-to-42-
amino acid peptide derived from the integral membrane Amyloid
Precursor Protein (APP), through sequential proteolytic cleavages
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FIGURE 2 | Structures and reactions of phosphatidylcholine
γ-hydroxyalkenals (PC-HAs). In addition to 2-pentylpyrrole-modification of
proteins by the electrophilic addition of HNE to ε-amino lysyl groups,
carboxyalkylpyrrole-modified proteins are also formed by adduct formation
with other γ-hydroxyalkenals (mirror images of esterified HNE) also formed,
at the time of HNE formation, from the oxidation of PUFA-containing
phospholipids. Legend: HHE, 4-hydroxy-2-hexenal; HNE, 4-hydroxy-2-nonenal;
PL-PC, 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine; PA-PC,
1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine; PD-PC,
1-palmitoyl-2-docosahexanoyl-sn-glycero-3-phosphocholine; HODA-PC,
9-hydroxy-12-oxo-10-dodecenoyl-phosphatidylcholine (this compound may
also derive from 1-linoleoyl-2-arachidonoyl-sn-glycero-3-phosphocholine,
LA-PC); HOOA-PC, 5-hydroxy-8-oxo-6-octenoyl-phosphatidylcholine;
HOHA-PC, 4-hydroxy-7-oxo-5-heptenoyl-phosphatidylcholine; PP-protein,
2-pentylpyrrole-modified protein; EP-protein, 2-ethylpyrrole-modified protein;
CPP-protein, carboxypropylpyrrole-modified protein; CEP-protein,
carboxyethylpyrrole-modified protein [Reprinted with permission from
Salomon et al. (2011)].
by β-secretase (BACE) and γ-secretase (Hardy and Selkoe, 2002).
HNE can react directly with the Aβ peptide. This process was
reported to exacerbate the formation of toxic Aβ-dependent
diffusible oligomers and insoluble aggregates, which, in turn,
enhanced oxidative stress, fromation of lipid peroxidation prod-
ucts, such as HNE, and Aβ oligomerization and toxicity (Siegel
et al., 2007). HNE modified the three histidyl residues of Aβ,
so that HNE-modified Aβ molecules had increased affinities for
membrane lipids and adopted a similar conformation as mature
amyloid fibrils (Murray et al., 2007; Liu et al., 2008).
HNE-α-enolase adducts
α-Enolase (non neural enolase, ENO1) is a multiform, multifunc-
tional protein. In the cytoplasm, it is a 48-kDa enzyme, catalyzing
2-phospho-D-glycerate dehydration to phosphoenolpyruvate. At
the cell surface of neutrophils, B and T cells, monocytes, epithe-
lial, endothelial cells and neurons, it serves as a plasminogen
receptor, involved in fibrinolysis (Pancholi, 2001) and in neu-
trophil andmonocyte recruitment (Busuttil et al., 2004;Wygrecka
et al., 2009). Binding to α-enolase protects plasmin from inac-
tivation by α2-antiplasmin (Bergman et al., 1997). Alternative
translation of α-enolase mRNA produces a 37-kDa protein, pref-
erentially located in the nucleus (myc Binding Protein-1, MBP-1),
with c-myc gene promoter-binding and tanscription repressing
activity (Feo et al., 2000; Subramanian and Miller, 2000). In
addition, α-enolase was reported to be a hypoxic stress pro-
tein (Graven and Farber, 1998). A regulatory circuit between
c-myc, MBP-1, and α-enolase was described, connecting cell
energy metabolism and proliferation (Sedoris et al., 2007). Redox
proteomic studies identified α-enolase as a target of oxida-
tive modification in all stages of Alzheimer’s disease, undergo-
ing the formation of carbonyl groups (Castegna et al., 2002;
Butterfield et al., 2006b; Sultana et al., 2006b), MDA adducts
(Pamplona et al., 2005), 4-HNE adducts (Reed et al., 2008, 2009a;
Perluigi et al., 2009), tyrosine nitration (Castegna et al., 2003;
Sultana et al., 2006a; Reed et al., 2009b) and S-glutathionylation
(Newman et al., 2007). A typical metabolic feature of AD is the
reduced rate of glucose metabolism, as seen in positron-emission
tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDG/PET)
(de Leon et al., 2001). Despite compensatory increases of α-
enolase expression in AD (Sultana et al., 2007) and even though
enzymatic activity was not assayed, it was suggested that the
loss of function associated with the oxidative modifications of
α-enolase might render neurons prone to apoptosis, by dysrupt-
ing their energy metabolism (Sultana et al., 2012). As peptide
Aβ(1-42), by aggregating in cross-β-structured fibrils, with a sim-
ilar conformation as fibrin peptides, could substitute for fibrin
in the activation of tissue plasminogen activator (tPA) (Kingston
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Table 1 | HNE-protein adducts detected in Alzheimer’s disease, in relation with disease progressiona.
Protein AD stagea Function References
Aldolase PAD, LAD Energy metabolism Perluigi et al., 2009
Triose phosphate isomerase (TPI) EAD Energy metabolism Reed et al., 2009a
Phosphoglycerate kinase (PGK) MCI Energy metabolism Reed et al., 2008
α-Enolase (non neural enolase, ENO1)b MCI, EAD,
LAD
Energy metabolism Reed et al., 2008, 2009a;
Perluigi et al., 2009
Pyruvate kinase (PK) M2 isoform PAD, MCI Energy metabolism Reed et al., 2008
Lactate dehydrogenase B (LDHB) MCI Energy metabolism Reed et al., 2008
Aconitase PAD, LAD Energy metabolism, mitochondrial function Perluigi et al., 2009
Malate dehydrogenase, mitochondrial EAD Energy metabolism, mitochondrial function Reed et al., 2009a
ATP synthase α subunit PAD, MCI,
EAD, LAD
Energy metabolism, mitochondrial function Reed et al., 2008, 2009a;
Perluigi et al., 2009
Mn Superoxide dysmutase (SOD2) EAD, LAD Mitochondrial function, antioxidant defense Perluigi et al., 2009; Reed
et al., 2009a
Carbonyl reductase 1 MCI Antioxidant defense Reed et al., 2008
Peroxiredoxin VI (Phospholipase A2) LAD Antioxidant defense Perluigi et al., 2009
Heme oxygenase 1 (HO-1) MCI, LAD Antioxidant defense Sultana et al., 2012
70-kDa heat shock protein (HSP70) MCI Stress response Reed et al., 2008
Pleckstrin homology-like domain, family A, member 2 (IPL) Signal transduction Reed et al., 2008
β-Actin MCI Cytoskeleton Reed et al., 2008
α-Tubulin LAD Cytoskeleton Perluigi et al., 2009
Elongation factor Tu (EF-Tu) PAD, MCI Protein synthesis Reed et al., 2008
Initiation Factor α (eIFα) MCI Protein synthesis Reed et al., 2008
Glutamine synthetase LAD Excitotoxicity Perluigi et al., 2009
Neuropolypeptide h3 PAD, MCI Neuronal communication Reed et al., 2008
Collapsin response mediated protein 2 (CRMP-2)c EAD, LAD Neuronal communication Perluigi et al., 2009; Reed
et al., 2009a
aClinical stages of Alzheimer’s disease (AD) progression, in chronological order: PAD, preclinical AD; MCI, mild cognitive impairment; EAD, early stage AD; LAD, late
stage AD.
bIntegral or perypheral membrane proteins of plasma or organelle membranes are underlined.
cAlso known as dihydropirimidinase-related protein 2 (DRP-2).
et al., 1995), and because plasmin cleaved peptide Aβ1-40 into
a truncated form, with potent stimulatory activity toward tPA
(VanNostrand and Porter, 1999), it was proposed that the loss
of plasminogen-binding activity of HNE-α-enolase might foster
apoptosis in AD, by hindering Aβ peptide degradation (Sultana
et al., 2012).
Such a scenario is supported by a functional study of HNE-
α-enolase adducts in HL-60 leukemic cells (Gentile et al., 2009).
α-Enolase was among a few proteins recognized by anti-histidine-
HNE antibodies, after 15min of exposure to 1–10μM HNE.
HNE–α-enolase adducts were detected early on the surface of HL-
60 cells, indicating a high degree of α-enolase exposure. HNE
treatment did not alter α-enolase expression or enzymatic activ-
ity. The low-level expression of an anti-α-enolase Ab-reactive
37-kDa peptide, possibly corresponding to MBP-1, did not vary
after HNE treatment. The main functional alteration of HNE-
α-enolase concerned its plasminogen-binding ability. Treatment
with 1μM HNE strongly inhibited plasminogen binding to α-
enolase at the cell surface and consequently reduced HL-60 cell
adhesion to human umbilical venous cells (HUVECs), suggesting
that HNE and other inhibitors of plasminogen binding to α-
enolase may be of use in the control of tumor invasion. α-Enolase
emerged from this study as a protein most susceptible to HNE
adduct formation, in keeping with various proteomic studies, in
the context of neurodegeneration, cited in section Alzheimer’s
Disease (AD), which pinpointed a limited number of protein tar-
gets of oxidative modification, including α-enolase, grouped in
selected functional subsets (Martínez et al., 2010; Reed, 2011;
Sultana et al., 2012). Some of these proteins targets were also iden-
tified as autoantigens frequently recognized by autoantibodies in
autoimmune diseases. α-Enolase, in particular, was recurrently
indicated as a novel autoantigen in systemic lupus erythemato-
sus (SLE), systemic sclerosis (SSc) (Moscato et al., 2000; Pratesi
et al., 2000; Mosca et al., 2006; Bussone et al., 2011), SSc with
interstitial lung fibrosis (Terrier et al., 2010), rheumatoid arthritis
(Goëb et al., 2009; Saulot et al., 2002), mixed cryoglobuline-
mia (MC) with nephropathy (Sabbatini et al., 1997; Moscato
et al., 2000; Pratesi et al., 2000), pulmonary arterial hyperten-
sion (Bussone et al., 2012), giant-cell arteritis (Régent et al.,
2011), Behçet’s disease (Lee et al., 2003) and inflammatory bowel
disease (IBD) (Roozendaal et al., 1998). Anti-α-enolase autoan-
tibodies isolated from patiens with SLE, SSc and MC recog-
nizedmembrane-associated α-enolase and inhibited plasminogen
binding to it (Moscato et al., 2000). It is tempting to speculate
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that the high susceptibility of α-enolase to modification by HNE
and other aldehydes might be instrumental for its involvement
in autoimmunity as an oxidatively modified self antigen, capable
of breaking the immunological tolerance of autoreactive T and
B cells. This is in keeping with the identification of α-enolase
among the proteins undergoing carbonyl addition and HNE
adduction in heart homogenates and cardiomyocytes oxidized
in vitro with 4-HNE or H2O2. Oxidative modifications correlated
with increased recognition of α-enolase by serum antibodies of
rodents and humans affected with Chagas’ disease, which is char-
acterized by increased production of ROS of inflammatory and
mitochondrial origin (Dhiman et al., 2012).
HNE adducts with other neuronal enzymes, transporters, and
receptors
Inducible heme oxygenase 1 (HO-1) catalyzes heme conversion to
biliverdin-IXa, which is further reduced to antioxidant bilirubin-
IXa (Mancuso and Barone, 2009). The expression of the HO-1
gene is redox-regulated by an antioxidant responsive element
in its promoter. Activation of HO-1 contributes to the adaptive
response to oxidative stress in AD (Poon et al., 2004). Increased
levels of HO-1 were observed in association with neurofibrillary
tangles (NFTs) and senile plaques (Takeda et al., 2000) and in
hippocampal neurons of AD patients, together with increases of
serine phosphorylation, tyrosine nitration and 4-HNE modifica-
tion of HO-1, as though adaptive increases in HO-1 expression
and activation were counteracting the structural and functional
impairment of HO-1, via tyrosine nitration and HNE-HO-1
adduct formation.
Collapsin response mediator protein 2 (CRMP2). Participates in
axon guidance and synapse maturation, by mediating the trans-
duction of reelin (Yamashita et al., 2006) and semaphorin 3A
signals (Uchida et al., 2009). Sultana et al. (2012) has proposed
that the HNE-CRMP2 adducts (Reed et al., 2008; Perluigi et al.,
2009) might be of pathogenic importance for neurite shortening
and the loss of synapses, early features of AD (Hensley et al., 2011;
Scheff et al., 2011), and that Aβ peptide-induced oxidation of pep-
tidylprolyl cis/trans isomerase (Pin1) (Butterfield et al., 2006b;
Sultana et al., 2006b) may be responsible for the dysregulation
of glycogen synthase kinase-3β (GSK-3β) and cyclin-dependent
kinase 5 (CDK5) and for the hyperphosphorylation of tau pro-
teins and of colocalized CRMP2 within NFTs (Williamson et al.,
2011).
Reduced glucose utilization and energy production (Rhein
and Eckert, 2007) are early occurrences in AD. They may be
explained by the reported formation of HNE adducts with neu-
ronal glucose transporter GLUT3 in rat hippocampal neurons
(Mark et al., 1997a) and with the mitochondrial ATP synthase
α subunit in human AD brains (Reed et al., 2008; Perluigi et al.,
2009; Terni et al., 2010). Decreased levels of ATP synthase activity
were also reported in AD (Schagger and Ohm, 1995). Soluble Aβ
peptide oligomers were responsible for electron-transport chain
dysruption, enhanced ROS generation, mitochondrial fragmen-
tation, and synaptic damage (Reddy et al., 2010), as well as for
enhanced HNE production (Mark et al., 1997b). ATP synthase
α subunit was colocalized with CRMP2 within NFTs (Sergeant
et al., 2003). In AD brains, LDL receptor-related protein 1 (LRP-
1), a membrane receptor involved in Aβ peptide removal, was
also covalently modified by HNE, which might contribute to the
extracellular deposition of amyloid substance (Owen et al., 2010).
Acrolein-protein adducts
Acrolein is neurotoxic in vitro. Moreover, in Alzheimer’s brains,
high levels of acrolein were detected in hippocampus and tempo-
ral cortex, where oxidative stress is high (Dang et al., 2010). Thus,
several studies addressed the mechanism of acrolein neurotoxic-
ity. Dang and coworkers (2010) showed that, in neuronal primary
cultures of hippocampal cells, acrolein exerted more toxic effects
than HNE. This might depend on the higher reactivity of
acrolein, which was an initiator of oxidative stress by forming
adducts with cellular nucleophilic groups in proteins, lipids, and
nucleic acids. Indeed, it was documented that in synaptosomal
proteins, exposed to high concentrations of acrolein, a loss of
thiol group content occurred, due to Michael adduct formation
between acrolein and thiol groups of proteins (LoPachin et al.,
2007). Moreover, such adduct formation led also to protein
cross-linking. Based on the cited evidence, LoPachin et al. (2002,
2003) proposed that nerve terminals were the primary sites of
acrolein action and that synaptic dysfunction was a necessary step
in the production of neurotoxicity. In support of this hypothesis,
in vivo and in vitro studies showed that exposure to acrolein was
associated with reduced presynaptic neurotransmitter release.
This effect involved inhibition of key proteins, which regulate
membrane–vesicle fusion, such as N-ethylmaleimide-sensitive
fusion protein (NSF) and synaptosomal-associated protein of
25 kDa (SNAP-25) (Barber and LoPachin, 2004; LoPachin, 2004).
Acrolein also inhibited presynaptic membrane neurotransmitter
uptake and vesicular storage in vivo and in vitro (LoPachin et al.,
2006; LoPachin, 2004). Proteomic analyses showed that these
dysfunctions were associated with the formation of adducts with
the dopamine transporter and v-ATPase, respectively Barber
and LoPachin, 2004; LoPachin, 2004; LoPachin et al., 2007;
Barber et al., 2007. In vitro studies showed that acrolein and HNE
disrupted synaptosomal membrane protein conformation and
phospholipid asymmetry (Subramaniam et al., 1997; Pocernich
et al., 2001; Castegna et al., 2004), reduced glutamate uptake
and GLUT3-mediated glucose transport in synaptosomes and
cultured nerve cells (Keller et al., 1997a,b; Lovell et al., 2000),
reduced respiration and induced oxidative stress in synaptosomal
mitochondria (Humphries et al., 1998; Morel et al., 1999; Picklo
et al., 1999; Picklo and Montine, 2001; Luo and Shi, 2005; Raza
and John, 2006), inhibited membrane Na+ and Ca2+ ion pumps
and dysrupted ion regulation in cultured nerve cells (Keller et al.,
1997b; Mark et al., 1997b).
MDA-protein adducts
A largely coincident protein repertoire as the one delineated
by anti-HNE antibodies was compiled by the immunochem-
ical detection of Nε-MDA-lysine. It included: α- (non neu-
ral) and γ-enolase (neural), glutamic acid dehydrogenase I,
creatin kinase B chain (CKB), ubiquinol-cytochrome c reduc-
tase complex core protein I, ATP synthase β subunit, glu-
tathione synthase (GS), 60-kDa heat shock protein (HSP-60),
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guanine nucleotide-binding protein G(I)/G(S)/G(T) β subunit 2
(GNB2), β- and γ-actin, α- and β-tubulin, vimentin, neurofila-
ment L, glial fibrillar acidic protein (GFAP), collapsin response
mediator protein 2, CRMP2, DRP-2) (Pamplona et al., 2005),
and 14-3-3 protein ζ (HYWAZ) and γ (HYWAG) isoforms
(Santpere et al., 2007).
A redox model of Alzheimer’s disease pathogenesis
Far beyond individual protein dysfunctions, the generation of
markers of lipid peroxidation in AD appears to be associated
with the progressive endangerment of vital processes, such as
energy metabolism, antioxidant defenses, signal transduction,
axonal transport, and synapse conservation. A redox model of
Alzheimer’s disease pathogenesis (Sultana et al., 2012) is depicted
in Figure 3.
FIGURE 3 | A redox model of Alzheimer’s disease pathogenesis.
Amyloid β-peptide (Aβ) is generated by proteolytic cleavage of Amyloid
Precursor Protein (APP) by secretases. Aβ undergoes aggregation, with the
formation of oligomers, which undergo a conformational transition to
β-structured diffusible oligomers and eventually deposit as amyloid plaques
in the ECM. Aβ oligomers insert in the plasma membrane, where they
initiate lipid peroxidation, leading to the formation of reactive aldehydes,
such as acrolein, MDA and HNE. Adduct formation compromises the
function of critical proteins in a number of functional subsets of
neurotransmission, energetic metabolism, mitochondrial function,
antioxidant defenses, represented here by collapsin response mediated
protein 2 (CRMP2), α-enolase, ATP synthase α subunit and heme
oxygenase 1. Such process is self-feeding and ultimately leads to
Alzheimer’s disease [Redrawn with permission from Sultana et al. (2012)].
ALDEHYDE-PROTEIN ADDUCTS IN ATHEROSCLEROSIS
The potential role of reactive aldehydes in the pathogenesis of
atherosclerosis was suggested by their increases in plasma in asso-
ciation with extensive aortic atherosclerosis and the high levels
of aldehydes generated during the oxidation of phospholipids
in LDLs (Salomon et al., 2000). The observed consequences
of LDL oxidation by aldehydes in vitro are described below.
The formation of protein-bound lipid peroxidation products in
atherosclerotic lesions was also repeatedly reported.
ALDEHYDE-LDL ADDUCTS
Early studies of the contribution of aldehyde-protein adducts to
atherogenesis provided evidences that modification of LDL by
aldehydes enhanced their recognition and uptake bymacrophages
(Hoff et al., 2003). The formation of aldehyde adducts with
apolipoprotein B (Apo B) in LDL converted the latter to an
atherogenic form that was taken up by macrophages, lead-
ing to the formation of foam cells (Steinberg et al., 1989;
Steinberg, 1995). The adduction products detected in Apo B of
oxidized LDL included: (a) acrolein derivatives, such as N-(3-
methylpyridinium)lysine (MP-Lys) (Obama et al., 2007) and the
3-formyl-3,4-dehydropiperidino adduct (FDP-lysine) formed by
the addition of two acrolein molecules to one lysyl side chain
(Uchida et al., 1998a,b); (b) HNE adducts, such as the enaminal-
type HNE-histidine and HNE-lysine adducts (Uchida et al.,
1994); (c) MDA adducts, such as Nε-(2-propenal)-lysine (Uchida
et al., 1997), and 1-amino-3-iminopropene-type MDA-lysine
cross-links (Requena et al., 1997). The formation of aldehyde-
LDL adducts could alter the binding of LDL to membrane scav-
enger receptors at the surface of endothelial cells and activated
macrophages. The participation of reactive aldehydes in LDL-
receptor interactions was documented by several immunohisto-
chemical analyses of atherosclerotic lesions from human aorta,
using antibodies against various aldehyde adducts, such as HNE-
histidine (Uchida et al., 1995), Nε-MDA-lysine (Uchida et al.,
1997), and Nε-acrolein-lysine (FDP-lysine) (Uchida et al., 1998a),
in which intense positivities were associated with cells, primar-
ily macrophages. It was recently reported that HNE–histidine
Michael adducts had significant affinities and interacted with
LOX-1 (lectin-like oxidized low-density lipoprotein receptor-1),
an important scavenger receptor mediating endothelial oxLDL
uptake. HNE-modified proteins strongly inhibited the uptake
of acetylated LDL (AcLDL). In human aortic endothelial cells,
the binding of HNE-histidine adducts to LOX-1 stimulated ROS
formation and activated extracellular signal-regulated kinase 1/2
(ERK 1/2) and NF-κB (Kumano-Kuramochi et al., 2012).
Using recombinant human Apo E (an exchangeable
antiatherogenic apolipoprotein) and immunoblotting with
acrolein-lysine-specific antibodies, other Authors (Tamamizu-
Kato et al., 2007) showed that acrolein severely compromised
the functional integrity of Apo E, as for heparin, lipid, and LDL
receptor binding. These results were in agreement with previous
observations of acrolein being widely present in atherosclerotic
lesion, as revealed by the use of anti-acrolein antibodies (Uchida
et al., 1998a). Nε-(3-methylpyridinium)-lysine (MP-Lys), an
acrolein derivative, was detected in Apo B of native LDL
(Obama et al., 2007). Moreover, acrolein-LDL induced foam
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cell formation from macrophages, suggesting that acrolein
maight contribute to LDL modification, foam cell formation and
atherogenesis (Watanabe et al., 2013).
PHOSPHATIDYLCHOLINE γ-HYDROXYALKENALS AND
ATHEROSCLEROSIS
Starting from the early observation that proteins modified by
2-pentylpyrrole incorporation of lysyl ε-amino groups, upon
covalent addition of HNE, accumulated in the blood of individ-
uals with atherosclerosis and in brain neurons of patients with
Alzheimer’s disease (Sayre et al., 1996), it became evident that
γ-hydroxyalkenal phospholipids and their ω-carboxyalkylpyrrole
derivatives contributed strongly in the pathogenesis of atheroscle-
rosis. This was the subject of recent reviews (Salomon and Gu,
2011; Stemmer and Hermetter, 2012). Antibody-based studies
revealed the presence of carboxyethylpyrroles (CHPs) and
carboxypropylpyrroles (CPPs) in oxLDL (Kaur et al., 1997). Also
the CHP immunoreactivity, reflecting the presence of protein
adducts of 9-hydroxy-12-oxo-10-dodecenoic acid (HODA) or
its phosphatidylcholine ester in human plasma, was significantly
higher in the plasma of patients with atherosclerosis and end-
stage renal disease than in healthy controls (Kaur et al., 1997).
HODA-protein adducts were produced in vivo from 9-hydroxy-
12-oxo-10-dodecenoyl-phosphatidylcholine (HODA-PC), one
of the oxidized lipids derived from 1-palmityl-2-arachidonoyl-
sn-glycero-3-phosphocholine (PA-PC), altogether referred to as
oxPA-PC. Chemically synthesized 5-hydroxy-8-oxo-6-octenoyl-
phosphatidylcholine (HOOA-PC) exhibited properties of a
chemical mediator of chronic inflammation. It activated, in
a dose-dependent manner, human aortic endothelial cells to
bind monocytes and to secrete increased levels of monocyte
chemotactic protein-1 (MCP-1) and interleukin-8 (IL-8), two
chemokines promoting monocyte entry into chronic lesions. It
also inhibited LPS-induced expression of E-selectin, an adhe-
sion molecule mediating endothelial-neutrophil interactions
(Subbanagounder et al., 2002). HOOA-PC was found unbound
and in pyrrole adducts in lipid extracts of oxLDL and human
atheromas (Podrez et al., 2002; Hoff et al., 2003). A scenario
emerged from these studies, in which atherogenesis might involve
myeloperoxidase-initiated, free radical-induced production of
oxPC, which promoted subendothelial monocyte infiltration and
endocytosis of oxLDL by macrophages, accompanied by conver-
sion into foam cells and atheroma formation (Salomon and Gu,
2011). Thereafter, it was shown that scavenger receptor CD36,
another mediator of oxLDL uptake by macrophages, at variance
with the LDL receptor, bound oxidized lipid derivatives within
oxLDL, including the derivatives of 1-palmitoyl-2-arachidonoyl-
glycerophosphocholine (oxPA-PC), such as HOOA-PC, and of
1-linoleoyl-2-arachidonoyl-glycerophosphocholine (oxLA-PC),
such as HODA-PC (Figure 2). These γ-oxygenated-α,β-
unsaturated aldehydes, collectively referred to as oxPCCD36,
were potent activators of the CD36-mediated endocytosis of
oxLDL by macrophages, promoting the cytotoxic effects of the
formation of protein adducts of electrophilic oxidized derivatives
of cholesterol and phospholipids (Salomon and Gu, 2011). As
an instance, the formation of Michael or pyrrole adducts of
HOOA-PC or HODA-PC to a cysteinyl thiol group of lysosomal
cathepsin B reduced the ability of mouse macrophages to degrade
internalized macromolecules (Hoff et al., 2003). OxLDL and
individual oxPCCD36 also interfered with the binding of HDL
to scavenger SR-B1 receptors of hepatocytes, thus inhibiting the
HDL-mediated delivery of cholesteryl esthers to the liver (Ashraf
et al., 2008).
HNE-SCAVENGER RECEPTOR B1 ADDUCTS AND KERATINOCYTE HDL
UPTAKE
Scavenger Receptor B1 (SR-B1), also known as HDL receptor,
is expressed in cells of the epidermal stratum corneum. In cul-
tured human keratinocytes, exposure to cigarette smoke caused
the translocation and eventual loss of SR-B1, driven by the acti-
vation of cellular NADPH oxidase (NOX) and the enhanced
H2O2 production. Cigarette smoke also caused the formation
of acrolein-SR-B1 and HNE-SR-B1 adducts and increased SR-B1
ubiquitination. It was proposed that such oxidation-dependent
modifications of SR-B1 subcellular localization and stability
might affect the physiological uptake of cholesterol by SC epider-
mal cells, which, in turn, might compromise their lipid composi-
tion and barrier function in the course of oxidative stress (Sticozzi
et al., 2012).
ALDEHYDE-PROTEIN ADDUCTS IN AUTOIMMUNITY
Modification of self antigens in the course of oxidative stress,
by adduct formation with reactive products of lipid peroxida-
tion, HNE being one of the most commonly involved, is generally
regarded to as a mechanism by which concomitant modifica-
tion of self and neoantigen formation may lead to the breaking
of tolerance to self antigens and, thus, to the pathogenesis of
autoimmune disease. Indeed, it was known for a long time that
abnormally high levels of HNE-protein adducts can be detected
in the sera of children affected by autoimmune diseases (Grune
et al., 1997). According to this view, cross-linking ofHNEwith self
antigens would be instrumental in creating neoantigens from for-
merly tolerated autoantigens and, thus, initiating autoimmunity.
HNE-PROTEIN ADDUCTS IN SJÖGREN’S SYNDROME (SS) AND
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Sjögren syndrome (SS) is an autoimmunity-driven chronic
infammatory disorder, characterized by infiltration and destruc-
tion of lacrimal and salivary glands by effector CD4+ and CD8+
T cells and activated macrophages, resulting in keratoconjunc-
tivitis with dry eyes and xerostomia (dry mouth). Secondary SS
can also add to the clinical picture of other autoimmune diseases,
such as systemic lupus erythematosus (SLE). Among autoim-
mune diseases, SS is second only to rheumatoid arthritis (RA) in
prevalence (1%), with affected females outnumbering males by
9–1. Antibodies to self antigens, such as anti-nuclear antibodies
(ANA), are characteristically found in SS, some of them being in
common with other autoimmune diseases, such as SLE, RA, and
systemic sclerosis (SSc). Typical ANA targets in SS include the SS-
A/Ro and SS-B/La proteins. The former include a 52-kDa form,
located in nucleus and in cytoplasm, (SS-A1/Ro52; TRIM21)
and a 60-kDa cytoplasmic form (SS-A2/Ro60; TROVE2). Both
are components of Ro ribonucleoprotein (RNP) particles, in
which they associate with short non-coding, histidine-rich RNAs
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(hY-RNAs). The 48-kDa SS-B/La antigen is a transcription ter-
mination factor for RNA Polymerase III, transiently associated
with hY-RNAs in ribonucleoprotein particles involved in tRNA
processing and histonic mRNA stabilization. Systemic lupus ery-
thematosus (SLE) is a multisystemic disease characterized by
a polyclonal B cell activation, leading to the differentiation of
plasma cells producing autoantibodies toward a broad range of
autoantigens. ANA are found in 95% of patients with SLE, as well
as in patients with other autoimmune diseases. They are heteroge-
neous and include antibodies toward: double stranded (ds) DNA;
histones; ribonucleoproteins (RNP), such as the Smith (Sm) anti-
gen (corresponding to the common core proteins of spliceosomal
small nuclear RNPs), and the SS-A/Ro and SS-B/La antigens. The
formation and deposition of immune complexes and comple-
ment in the wall of small arteries, at the dermo-epidermal junc-
tion and in the glomerular basalmembrane (GBM) is responsible,
respectively, for the diffuse necrotizing vasculitis, the cutaneous
lesions of erythematous, bullous, and ulcerative kind, and the
nephritis associated with SLE.
Notwithstanding their nuclear and/or cytoplasmic location,
Ro and La antigens appeared to become exposed at the cell
surface in the course of apoptosis. Epitopes expressed at the
surface of apoptotic cells are named “apotopes.” After the first
observations of the clustering of cytoplasmic and nuclear anti-
gens, including SS-Ro and SS-La antigens, in two types of blebs
at the surface of apoptotic cells (Casciola-Rosen et al., 1994),
the accessibility of SS-A/Ro and SS-B/La antigens at the sur-
face of apoptotic cells was further confirmed (Miranda-Carús
et al., 2000; Ohlsson et al., 2002). In SLE and SS, both the num-
ber of circulating apoptotic leukocytes and the susceptibility of
lymphocytes to activation-induced apoptosis in vitro increased
(Emlen et al., 1994; Georgescu et al., 1997; Zeher et al., 1999;
Ren et al., 2003). Impaired efferocytosis (clearance of apoptotic
cells) by macrophages also contributed to the higher degree of
exposure to autoantigens determined by the increased rate of
apoptosis in SLE (Ren et al., 2003). It was speculated that both
factors may trigger autoimmunity (Savill et al., 2002). It was
proposed (Casciola-Rosen et al., 1994) that the breaking of tol-
erance to autoantigens at the surface of apoptotic cells might be
favored by oxidative modifications occurring as a result of the
oxidative stress that characterizes apoptosis (Hockenberry et al.,
1993).
The contribution of the formation of HNE adducts to the
modification of self antigens, such as SS-A2/Ro60, in Sjögren’s
syndrome was explored by Scofield and coworkers. They hypothe-
sized that modification of SS-A2/Ro60 with HNE might facilitate
the breaking of tolerance to the self antigen. After immunizing
rabbits with either HNE-modified or unmodified SS-A2/Ro60,
they observed that autoimmunity was established faster and
more strongly in animals immunized with HNE-modified SS-
A2/Ro60 (Scofield et al., 2005). In an extension of this model,
an SS-like condition, with anti-SS-A2/Ro60 antibodies, decreased
salivary flow and salivary gland mononuclear infiltrates, could
be induced in BALB/c mice by immunization with a peptide of
SS-A2/Ro60 (Kurien et al., 2011). Efficient production of anti-SS-
A2/Ro60 and anti-SS-B/La autoantibodies ensued immunization
with SS-A2/Ro60, both as such and modified with increasing
concentrations of HNE (0.4, 2, or 10mM). However, antibody
production was faster after low- and medium-level modifica-
tion of SS-A2/Ro60 with HNE. Differential use of unmodified
or HNE-modified SS-A2/Ro60 as the solid-phase substrate in
ELISAs for autoantibodies revealed, among the antibodies pro-
duced by mice immunized with HNE-modified SS-A2/Ro60, an
additional subpopulation of antibodies, which recognized HNE
or HNE-SS-A2/Ro60, but not unmodified SS-A2/Ro60. Most
interestingly, immunization with medium-level HNE-modified
SS-A2/Ro60 was accompanied by the appearance of anti-dsDNA
autoantibodies, which induced the Authors to imply a SLE-like
disease, although they did not provide pathological evidence
of it. Together with the already mentioned appearance of anti-
SS-B/La antibodies, following immunization with SS-A2/Ro60,
the occurrence of anti-dsDNA antibodies represented an exam-
ple of intermolecular epitope spreading. In turn, the ability of
HNE to form adducts with a large number of biological macro-
molecules could be of help in understanding the broad range of
autoantibody responses in SLE and SS. Moreover, immunization
with high-level HNE-modified SS-A2/Ro60 was associated with
weaker antibody responses to unmodified SS-A2/Ro60 and SS-
B/La, reduction of salivary flow and lymphocytic infiltration of
salivary glands, suggesting a Sjögren’s syndrome-like condition.
Notably, high-level HNEmodification of SS-A2/Ro60 was accom-
panied by aggregation, which prompted the Authors to interpret
the results as due to increasing bifunctional cross-linking of
SS-A2/Ro60 and diminished exposure of HNE at the surface
of SS-A2/Ro60 molecules (Kurien et al., 2011). A more likely
interpretation could be that large, particulate immunocomplexes
of aggregated HNE-SS-A2/Ro60 and autoantibodies stimulated
the phagocytic and antigen-presenting activity of macrophages,
which skewed the autoimmune response toward a prevailingly
cytotoxic cell-mediated mechanism.
The molecular mimicry between the adducts of lipid peroxida-
tion products with proteins and nucleic acids, as a possible mech-
anism initiating the production of anti-DNA autoantibodies, in
response to some other modified self antigen, was the subject of
interesting studies by Uchida and coworkers. After raising an anti-
HNE monoclonal antibody (anti-R mAb 310), recognizing enan-
tioselectively (R)-HNE-histidine Michael adducts (Hashimoto
et al., 2003), they unexpectedly found that the sequence of this
anti-HNE mAb was highly similar to those of various clonally
related anti-DNA antibodies. Despite these structural similarities,
the cross-reactivity of mAb R310 with native dsDNA was lim-
ited, but was strongly enhanced by treating DNA with 4-oxo-2-
nonenal (ONE), a HNE analog. The 7-(2-oxo-heptyl)-substituted
1,N2-etheno-type ONE-2’-deoxynucleoside adducts were identi-
fied as alternative epitopes of mAb R310 in ONE-modified DNA.
On these grounds, these Authors hypothesized that endogenous
reactive electrophiles, like HNE, might function as immuno-
logic triggers for human autoimmunity (Akagawa et al., 2006).
These Authors further investigated the possible involvement of
HNE-modified proteins as the endogenous source of anti-DNA
antibodies. They found HNE-specific epitopes in the epider-
mis and dermis of patients with SLE, pemphigus vulgaris and
contact dermatitis, as well as antibodies against HNE-modified
bovine serum albumin (BSA) in the sera of patients affected with
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SLE, Siögren’s syndrome, rheumatoid arthritis, systemic sclero-
sis and idiopathic inflammatory miopathies, and also in the sera
of diseased MRL/lpr mice. Upon repeated immunization with
HNE-modified KLH, mice developed also a subpopulation of B
cell clones recognizing native DNA, but not HNE-BSA. In agree-
ment with previous results, the reactivity of anti-HNE B cell
clones toward DNA was greatly enhanced by DNA modification
with ONE. On the other hand, anti-DNA mAbs cross-reacted
with ONE-modified BSA. These data suggested that HNE-specific
epitopes produced upon physiological generation of HNE in
cells might serve as triggering antigens for the development
of bispecific antibodies against native DNA and ONE-modified
proteins. On the whole, these findings strongly supported the
pathogenic role of lipid peroxidation products in autoimmune
disease (Toyoda et al., 2007). The pathogenic role of lipid per-
oxidation in SLE and the potential usefulness of anti-MDA and
anti-HNE antibody titers in predicting its progression was under-
scored also by a report showing that the prevalences and serum
levels ofMDA- andHNE-protein adducts, as well as ofMDA- and
HNE-specific antibodies, were significantly higher in SLE patients
than in healthy controls, and were in correlation with the SLE
Disease Activity Index. The levels of each aldehyde-protein adduct
were also in correlation with the titers of the respective antibodies
(Wang et al., 2010).
ALDEHYDE-PROTEIN ADDUCTS AND STRUCTURAL
INTEGRITY, ION TRANSPORT, AND SIGNAL TRANSDUCTION
AT THE PLASMA MEMBRANE LEVEL
HNE is the product of lipid peroxidation which has been shown
to be mostly involved in the control of cell functions. Under phys-
iological conditions, HNE can be found at low concentrations in
human tissues and plasma (Parola et al., 1998; Okada et al., 1999;
Ji et al., 2001; Siems and Grune, 2003), where it participates in
the control of signal transduction, cell proliferation and differen-
tiation (Parola et al., 1998). HNE-protein adducts in peripheral
blood primarily involve albumin, transferrin and immunoglobins
(Barrera et al., 1996). Adducts between HNE and proteins have
been detected in vitro in various mammalian cell types (Parola
et al., 1998; Okada et al., 1999; Ji et al., 2001; Siems and Grune,
2003), in which the percent of total added HNE in HNE-protein
adducts was between 1 and 5% (Rinaldi et al., 2001). Some
adducts of HNE with cell proteins involved in specific functions
at the plasma membrane level were characterized in detail.
HNE-SPECTRIN ADDUCTS AND RED CELL MEMBRANE INTEGRITY
Spectrin is the main component of the submembranous
cytoskeleton lining the intracellular side of the plasma membrane
of red blood cells, playing a fundamental role in maintaining
its stability and strength, via direct interactions with membrane
lipids and the actin cytoskeleton. Immunoblotting andmass spec-
trometric analyses revealed that, in human red cells, α- and
β-spectrin were the primary targets of HNE adduction. Exposure
of intact red cells to HNE resulted in selective HNE-spectrin
adduct formation, with preferential β-spectrin modification and
cross-linking of HNE-modified spectrin molecules. The Authors
speculated that local spectrin aggregation, by freeing the lipid
bilayer from the underlying spectrin-actin cytoskeleton, might
lead to membrane surface area loss by extrusion (Arashiki et al.,
2010). Together with the reported accumulation of HNE in aging
circulating red blood cells (Ando et al., 1995), these observations
may be of relevance not only for the physiological destruction of
aged red cells, but also for the immune-mediated hemolysis of
red blood cells under conditions of enhanced production of lipid
hydroperoxides.
HNE-Na+-K+-ATPase ADDUCTS
Na+-K+-ATPase is an integral plasmamembrane protein of great
functional importance. Its primary functions are the mainte-
nance of intracellular K+ ion levels and the excretion of Na+
ions. It contains 70 cysteinyl residues per molecule. The bind-
ing of HNE at 1–10μmolar concentration to Na+-K+-ATPase
was rapid and was accompanied by a decrease in measurable SH-
groups and an irreversible loss of enzyme activity (Siems et al.,
1996). Na+-K+-ATPase could be attacked by HNE formed both
intra- and extracellularly, due to the free access of HNE to inte-
gral plasmamembrane proteins. These Authors suggested that the
reduction of Na+-K+-ATPase activity upon covalent HNE bind-
ing might represent an important form of secondary oxidative
cell damage. Their findings were confirmed by the demonstration
that in cultured hippocampal neurons HNE impaired Na+-K+-
ATPase activity and induced increases of intracellular Ca2+ ion
concentration (Mark et al., 1997b).
HNE ADDUCTS WITH TYROSINE KINASE RECEPTORS
Tyrosine kinase receptors (RTKs), such as the epidermal growth
factor receptor (EGFR) and the platelet-derived growth fac-
tor receptor (PDGFR), are transmembrane glycoproteins, dis-
playing tyrosine kinase activity in their cytoplasmic domains.
Stimulation of RTKs by ligand-dependent or -independentmech-
anisms (radiation, metal ions, ROS) induces receptor dimeriza-
tion and autophosphorylation of tyrosyl residues, followed by
catalytic activation, whereas downregulation of RTKs is medi-
ated by internalization and dephosphorylation (Pawson and
Scott, 1997). Oxidized LDL (but not native LDL) and free HNE
induced in living cells the formation of HNE-EGFR and HNE–
PDGFR adducts, evidenced by the binding of anti-HNE-protein
antibodies and by the loss in free −NH2 group content (Suc
et al., 1998; Hubbard and Till, 2000; Escargueil-Blanc et al.,
2001). At physiological ormoderate HNE concentrations (0.1μM
and 1–10μM), the formation of HNE-EGFR and HNE-PDGFR
adducts resulted in sustained RTK activation (Suc et al., 1998;
Escargueil-Blanc et al., 2001). A short incubation of vascular
smooth muscle cells (SMCs) with a low concentration of HNE
(0.1–1μM) induced the derivatization and autophosphorylation
of RTKs, with the consequential activation of the phosphatidyli-
nositol 3-kinase (PI3K)/Akt-mediated survival pathway and of
the mitogenic response of SMCs (Auge et al., 2002). On the
other hand, high concentrations of HNE, for longer incubation
times, inhibited EGFR- and PDGFR-mediated cell proliferation
(Liu et al., 1999; Vindis et al., 2006), through inhibitory effects
on RTK signaling (Negre-Salvayre et al., 2003). High doses of
HNE exerted similar negative effects on proteasomes (Okada
et al., 1999; Vieira et al., 2000), mitochondrial transition pores
(Irwin et al., 2002), glyceraldehyde-3-phosphate dehydrogenase
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(Uchida and Stadtman, 1993) and cathepsin B activities (Crabb
et al., 2002). The inhibitory effect of 4-HNE on growth
factor-dependent cell proliferation was in agreement with the
progressive desensitization of PDGFR β subunit to its ligand
PDGF B-chain in SMCs (Vindis et al., 2006). In other cell types,
low HNE concentrations (1μM) did not cause RKT activa-
tion. In human hepatic stellate cells (hHSC), 1μM HNE rather
inhibited tyrosine autophosphorylation of PDGFR β induced
by the PDGF BB isoform, which resulted in the inhibition of
the mitogen-activated protein kinase (MAPK) and PI3K cas-
cades and a consequential decrease of PDGF-dependent DNA
synthesis (Robino et al., 2000). Acrolein was also shown to
be a potent inactivator of protein tyrosine phosphatase 1B
(PTP1B), a member of an important class of cysteine-dependent
enzymes, working in tandem with protein tyrosine kinases in
the regulation of a number of signal transduction pathways
(Seiner et al., 2007).
HNE ADDUCTS WITH PROTEINS IN THE INSULIN SIGNALING
CASCADES
The regulation of insulin signaling starts with the binding of
insulin to its receptor, whose tyrosyl residues are rapidly phos-
phorylated. This permits the recruitment of adaptor proteins,
such as insulin receptor substrates (IRSs) and Src homology-
2-containing (Shc) proteins, which transmit the insulin signal
down the PI3K cascade for glucose, lipid, and protein metabolism
and the MAPK cascade for cell proliferation and differentiation
(Saltiel and Kahn, 2001; Van Obberghen et al., 2001; White,
2002; Taniguchi et al., 2006). Reductions in the levels of IRSs
and insulin-induced IRSs and a decrease in insulin receptor β
phosphorylation were observed upon exposure to HNE at non-
toxic concentrations (Demozay et al., 2008). Such effects could be
due to the formation of HNE-IRS adducts, likely impairing IRS
function and favoring IRS degradation. The downstream signal-
ing cascades, involving PI3K and protein kinase B (PKB), were
also down-regulated upon exposure to HNE, which resulted in
blunted metabolic responses. The Authors of this study hypoth-
esized that HNE build-up in diabetic rats (due to increased lipid
peroxidation and altered clearance of its products by detoxifying
enzymes) might be a cause of signaling dysfunction, hindering
insulin action.
CONCLUSIONS
The adducts of reactive aldehydes with membrane proteins par-
ticipate in physiological, as well as pathological processes and
can determine variable functional consequences, in relation with
the protein targets of adduction and their functional roles.
Polyclonal and monoclonal antibodies directed against protein-
bound aldehyde adducts have been of great help in exploring the
aldehyde-related modifications of the cell proteome, while mass
spectrometry-based techniques have been playing a key role in
elucidating the stoichiometry and sites of covalent protein mod-
ification with reactive aldehydes. Nonetheless, the inventory of
aldehyde-modified membrane proteins detected so far is prob-
ably still largely incomplete, when compared with the plethora
of biological effects displayed by these molecules. Quantitative
technical limitations in the individuation of aldehyde-protein
adducts are being gradually overcome by the increases in sensi-
tivity, molecular specificity and tolerance to impurities of spec-
trometric instrumentation and techniques (Wu and Vogt, 2012).
Current challenges include: (1) characterizing the functional con-
sequences of cell protein modification with aldehydes, which
was not addressed by most redox proteomic studies published
until now. This may involve major efforts of expression, recon-
stitution, modification and activity/interactivity assays of protein
targets of aldehyde modification in vitro, as well as innovative
approaches of protein-specific tracking and functional character-
ization at the cellular level; (2) clarifying the sources, sites and
circumstances of increased lipid peroxidation in cells and the
topological/functional relationships (e.g., in terms of subcellu-
lar compartmentalization and regulation of gene expression and
gene product activity) linking the increased generation of reac-
tive aldehydes with the modifications of specific cell membrane
proteins.
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